A Global Analysis of the Adaptations Required for Sterol Catabolism in Mycobacterium Tuberculosis: A Dissertation by Griffin, Jennifer E.
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Dissertations and Theses Graduate School of Biomedical Sciences 
2011-05-20 
A Global Analysis of the Adaptations Required for Sterol 
Catabolism in Mycobacterium Tuberculosis: A Dissertation 
Jennifer E. Griffin 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss 
 Part of the Bacteria Commons, Genetic Phenomena Commons, Genetics and Genomics Commons, 
Lipids Commons, Polycyclic Compounds Commons, and the Systems Biology Commons 
Repository Citation 
Griffin JE. (2011). A Global Analysis of the Adaptations Required for Sterol Catabolism in Mycobacterium 
Tuberculosis: A Dissertation. GSBS Dissertations and Theses. https://doi.org/10.13028/f3f8-ad07. 
Retrieved from https://escholarship.umassmed.edu/gsbs_diss/571 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and 
Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
A GLOBAL ANALYSIS OF THE ADAPTATIONS REQUIRED FOR STEROL 
CATABOLISM IN MYCOBACTERIUM TUBERCULOSIS 
 
 
 
A Dissertation Presented 
 
By 
 
JENNIFER ELIZABETH GRIFFIN 
 
 
Submitted to the Faculty of the 
 
University of Massachusetts Graduate School of Biomedical Sciences, Worcester 
 
in partial fulfillment of the requirements for the degree of 
 
 
 
DOCTOR OF PHILOSOPHY 
 
 
 
May 20, 2011 
 
Program in Molecular Genetics and Microbiology
A Dissertation Presented 
 
By 
 
Jennifer Elizabeth Griffin 
 
 
The signatures of the Dissertation Defense Committee signifies  
completion and approval as to style and content of the Dissertation 
 
 
Christopher Sassetti, Ph.D., Thesis Advisor 
 
 
Jon Goguen, Ph.D., Member of Committee 
 
 
Victor Boyartchuk, Ph.D., Member of Committee 
 
 
Bert Van den Berg, Ph.D., Member of Committee 
 
 
Eric Rubin, M.D., Ph.D., Member of Committee 
 
The signature of the Chair of the Committee signifies that the written dissertation 
meets the requirements of the Dissertation Committee 
 
 
John Leong, M.D., Ph.D., Chair of Committee 
 
The signature of the Dean of the Graduate School of Biomedical Sciences 
signifies that the student has met all graduation requirements of the school. 
 
 
Anthony Carruthers, Ph.D.,  
Dean of the Graduate School of Biomedical Sciences 
 
 
Program in Molecular Genetics and Microbiology 
 
 
May 20, 2011 
"""
Acknowledgements 
 
 
First and foremost I need to thank my advisor, Chris.  I could have never known 
how fortunate I would be to call him my mentor.  Not only exceptionally 
intelligent, but also deeply grounded, Chris naturally brings out the best in people 
with his seemingly limitless amount of patience and optimism.  And even as I 
leave the bench, I am immensely grateful that he remains one of my biggest 
supporters. 
 
I’m also grateful for the fabulous group of people he has assembled.  Thank you 
to the many members, past and present, of the Sassetti Lab. You have made it 
easy to come to lab everyday. Thank you for the laughs, too numerous to count, 
and for broadening my horizons past the Massachusetts state line. 3pm will 
always be teatime in my book. 
 
This work is truly a testament to the large support network I am so lucky to have 
in my life.  To my husband, Joe, thank you for giving me a sense of perspective, 
when frustration and impatience would have otherwise consumed me. You are 
my rock.  To my parents, thank you for raising me to believe there was nothing in 
this world I couldn’t do.  To my sister, Amanda, here’s to earning your own Ph.D. 
in less than the 6 years it took me. I’m glad I’ll be there for you along the way.  
 
"#
Lastly, thank you to the dedicated members of my thesis and dissertation 
examination committee.  In addition to running your own successful laboratories, 
you never failed to find time for advice, support and to show genuine interest in 
my studies.  Your selflessness has not gone unnoticed and is deeply 
appreciated. 
#
Abstract 
 
 
Systems biology approaches have allowed for comprehensive understanding of 
complicated biological processes.  Here, we’ve developed a global phenotypic 
profiling method by improving upon transposon mutagenesis methods for 
identifying genes required for bacterial growth in various conditions.  By using the 
massively parallel power of Illumina sequencing, we precisely redefined the 
genes required for the growth of Mycobacterium Tuberculosis (Mtb) in vitro.  This 
adapted technique provided more informative data with both increased dynamic 
range and resolution.  As a result, we quantitatively assessed the fitness of 
individual mutants, as well as identified sub-genic essentiality.  Mtb is well 
adapted to its nutrient-limiting intracellular niche.  One important and novel 
adaptation is its ability to consume cholesterol for both energy and carbon.  A 
combination of this genome-wide phenotypic analysis and global metabolite 
profiling was used to define the dedicated cholesterol catabolic pathway, as well 
as important transcriptional and metabolic adaptations required for the 
consumption of this carbon source.   We identified the methylcitrate cycle (MCC) 
and an unexpected gluconeogenic route as essential pathways.  Furthermore, 
we found that the cholesterol-dependent transcriptional induction of these 
metabolic enzymes was also essential for growth on this substrate, a function 
mediated by the Rv1129c regulatory protein. Using a combination of genetic and 
chemical methods to inhibit these pathways, we show that cholesterol represents 
a significant source of carbon during intracellular growth in macrophages.  
#"
Finally, we have begun to define the mechanism by which lipids, such as 
cholesterol, are imported into the cell by investigating the assembly of the ABC-
like lipid transporter, Mce1.  The subunits of this system are localized to the cell 
wall and data is provided to support a novel mechanism for Mce-dependent 
import of lipids, such as cholesterol.  In sum, this global analysis of host 
cholesterol utilization during infection provides insight into each step of this 
complicated process; import into the bacterial cell, the degradation of the 
molecule into primary metabolites, and the transformation of these metabolites 
into carbon and energy. 
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Chapter I. Introduction 
Overview 
Tuberculosis (TB) has plagued mankind since the early days of human 
civilization.  Sequence diversity analysis suggests that TB existed during the 
early human migrations out of Africa 50,000 years ago (Hershberg et al. 2008).  
Evidence for various manifestations of TB, including skeletal abnormalities like 
Pott’s disease, can be found in both ancient Egyptian mummies and artwork from 
5,000 years ago (Cave 1939, Daniel 2006, Morse et al. 1964, Zimmerman 1979).  
Archaeological evidence places TB not only in ancient Egypt, but also ancient 
Peru and all across Europe throughout the Middle Ages (Daniel 2006, Salo et al. 
1994).  By the early part of the 19th century, TB was devastating European and 
North American cities in epidemic proportions claiming between 800-
1,000/100,000 lives per year (Grigg 1958a, Grigg 1958b, Krause 1928).  In 1804, 
René Théophile Hyacinthe Laennec argued that the various presentations and 
pathologies of TB were in fact, one disease.  It was not until 1882 that Robert 
Koch identified the etiologic agent (Daniel 2004, Sakula 1982).  Koch’s seminal 
work not only identified Mycobacterium tuberculosis (Mtb) as the causative agent 
of TB, but also defined what are still known today as Koch’s postulates, which 
determined the criterion of infectious disease and gave rise to the science of 
bacteriology.  Almost 130 years later, one third of the world is latently infected 
with Mtb and close to 2 million people die annually from TB (WHO 2010).  
Though modern issues, such as HIV co-infection and drug-resistant strains 
&
complicate the current TB landscape, the root of the issue remains the same: a 
lack of understanding of the basic physiology of such a complicated killer. 
  
Mtb is an acid-fast, rod shaped bacillus with close to 4000 predicted open 
reading frames (ORF) (Cole et al. 1998).  Phylogenetically classified as gram-
positive, the organization of its complex and unique, lipid-laden cell wall mimics 
that of a gram-negative organism (Hoffmann et al. 2008, Zuber et al. 2008).  Mtb 
contains a single circular chromosome that is 65.6% G+C rich (Cole et al. 1998).  
With a generation time of 19-24 hours in vitro, an extremely hydrophobic cell wall 
and a biosafety level 3 classification, Mtb plagues both patients and scientists 
alike. 
 
TB Disease 
Mtb is a successful pathogen in part, because it elicits a chronic disease.  Only 
approximately 10% of infected individuals will develop active pulmonary TB 
characterized by weight loss and persistent productive cough (Flynn and Chan 
2001, Kaufmann 2001).  The majority of the remaining individuals develop a 
clinically defined latent disease, characterized by infection without symptoms.  
Latently infected individuals are non-infectious, but skin test positive and make 
up a huge reservoir of potentially deadly future infections.  Latent infections carry 
a 10% lifetime risk of reactivation (Horsburgh 2004). This risk increases 
dramatically to a 10% annual risk among latently infected human 
'
immunodeficiency virus (HIV) positive individuals (Whalen et al. 1997, Selwyn et 
al. 1992, Selwyn et al. 1989).  The requirements and mechanisms for reactivation 
of TB disease are not well defined, but it is clear that an immunocompromised 
state favors reactivation.  
 
Current methods for treatment of TB include both prophylactic and therapeutic 
measures.  In the 1930s the development of the bacillus Calmette-Guérin (BCG) 
vaccine for TB was generated using the zoonotic pathogen M. bovis, the 
causative agent of TB in cattle and many other mammals.  M. bovis was passed 
hundreds of times on bile potatoes to render an immunogenic, but avirulent 
organism that was and is still used in some countries today to vaccinate infants 
against Mtb (Calmette 1931).  Unfortunately, BCG is ineffective against adult 
pulmonary TB and elicits a varied protective response to infant pulmonary TB 
(Fine 1995, Kaufmann 2010).  BCG vaccination now occurs only in countries 
where TB is endemic and the population is at high risk of serious complications.  
With the varied protectiveness of BCG, the main burden of TB treatment lies on 
therapeutic measures.  Current antitubercular therapies to treat active, drug-
sensitive TB include a cocktail of first-line drugs administered for six to nine 
months (LoBue et al. 2010).  These include isoniazid (INH), rifampin (RIF), 
pyrazinamide (PZA) and ethambutol (EMB).  In patients where these drugs fail, 
second-line drugs, which include flouroquinolones and aminoglycosides are 
administered.  These drugs are toxic, broad-spectrum antibiotics saved for use 
(
against drug-resistant strains.  Recent surveys estimate 440,000 new cases of 
multiple drug-resistant tuberculosis (MDR-TB) globally in 2008 and have 
identified extensively drug-resistant (XDR-TB) strains in 58 countries and 
territories (WHO 2010).  Like MDR-TB, XDR-TB is resistant to RIF and INH, but 
also to many less-effective second line drugs.  It is clear that new antitubercular 
measures are needed to combat an increasing epidemic of untreatable TB.  
 
Mtb Pathogenesis 
Despite our inability to tackle this human pathogen on a global scale, the past 
century has generated a wealth of insight into the molecular pathogenesis of Mtb.  
We understand that following inhalation, the bacterium is engulfed by alveolar 
macrophages, where it is uniquely adapted for survival (Leemans et al. 2001).  
Following phagocytosis, macrophages employ an arsenal of molecular 
mechanisms that result in destruction of foreign invaders, including acidification 
of the phagosome, an increase in reactive oxygen and nitrogen species, 
antimicrobial peptides and hydrolytic enzymes (Liu and Modlin 2008).  The main 
strategy employed by Mtb against the macrophage is one of evasion.  By halting 
the fusion of mycobacterial phagosomes with lysosomes, Mtb generates a 
protective niche in which it evades further macrophage and immune insults 
(Armstrong and Hart 1971).  Mtb is believed to accomplish this by inhibiting the 
recruitment of the vacuolar proton ATPase pump and maintaining a pH of 6.4 
within the infected phagosome (Armstrong and Hart 1971, Sturgill-Koszycki et al. 
)
1994).  During this time, the mycobacterial phagosome is maintained within the 
early endosomal recycling network and is thought to have access to cellular 
membranes and the extracellular milieu (Clemens and Horwitz 1996, Russell et 
al. 1996). During this acute phase of infection, Mtb replicates unabated and it is 
not until the onset of the adaptive immune response that bacterial growth is 
halted. 
 
The Intracellular Environment 
The ability of Mtb to initially thrive in the face of host insults is remarkable 
considering its hostile intracellular environment.  In addition to the toxic 
molecules resulting from the oxidative burst and low pH, the phagosome also 
presents a nutritional challenge for Mtb.  Depriving pathogens of nutrients is an 
effective antimicrobial mechanism and while challenging to analyze directly, it 
has been indirectly demonstrated by auxotrophic mutants and bacterial 
transcriptional responses.  The inability of several mycobacterial auxotrophs to 
survive in vivo suggest that purines, certain amino acids such as leucine, lysine 
and proline, and even pantothenate are limiting in the phagosome (Hondalus et 
al. 2000, Jackson et al. 1999, McAdam et al. 1995, Pavelka et al. 2003, 
Sambandamurthy et al. 2002).  In addition, several groups have investigated the 
in vivo transcriptional response of Mtb and their results all confirmed that Mtb 
was mounting a response to a nutrient-limiting, specifically a carbohydrate-
limiting, environment (Schnappinger et al. 2003, Homolka et al. 2010, Dubnau et 
*
al. 2002, Timm et al. 2003).  Schnappinger and colleagues in particular, found 
that Mtb upregulates the expression of 18 genes all predicted to encode !-
oxidation functions, suggesting Mtb shifts its intracellular metabolism to a lipid-
based diet.   
 
The Lipid Diet of Mtb 
The idea that Mtb consumes lipids was first suggested in the 1950s when Segal 
and Bloch demonstrated that Mtb isolated from lungs of infected mice could 
preferentially use fatty acids over carbohydrates to stimulate cellular respiration 
(Bloch and Segal 1955).  In addition, a single nucleotide polymorphism in pykA 
(pyruvate kinase) in the closely related species M. bovis, renders this bacterium 
unable to fully catabolize sugars, requiring the metabolism of non-carbohydrate 
carbon sources, such as lipids to support growth (Keating et al. 2005).  Further 
support was generated in 1998 when the Mtb genome was sequenced and over 
250 genes predicted to have roles in lipid metabolism were identified (Cole et al. 
1998).  Not only where many of these lipid metabolism genes upregulated in vivo 
(Schnappinger et al. 2003), but some are also required for virulence (Brzostek et 
al. 2007, Chang et al. 2007, McKinney et al. 2000, Muños-Elías et al. 2005, 
Sassetti et al. 2003).  By studying one such gene, icl, the metabolic switch to 
lipids became further delineated. 
 
+
icl encodes the enzyme isocitrate lyase, which cleaves isocitrate to glyoxylate 
and succinate and represents the first step of the glyoxylate cycle (McKinney et 
al. 2000). The glyoxylate cycle is an important anapleurotic modification to the 
TCA cycle and is required for growth on carbon sources that are converted to 
acetyl CoA (C2 compounds).  !-oxidation of fatty acids and other lipids generate 
C2 compounds and therefore, require the glyoxylate cycle.  Interestingly, Mtb 
specifically requires icl during the chronic phase of disease in mice (McKinney et 
al. 2000).  Since the hallmark of chronic disease is the activation of the 
macrophage via the cytokine interferon gamma (IFN"), this suggested that Mtb 
metabolism was modified by the activation state of the macrophage.  Lipid 
metabolism therefore, may be a necessary adaptation to the nutrient-limiting 
activated macrophage. 
 
Mtb and Cholesterol 
The evidence that Mtb shifted its metabolism intracellulary from carbohydrates to 
lipids was mounting.  Clues to the identity of the lipid(s) were generated in 2007, 
when Van der Geize and colleagues identified a region in the chromosome of a 
related actinomycete, Rhodococcus sp. strain RHA1 (RHA1), that was 
specifically upregulated following growth on cholesterol (Van der Geize et al. 
2007).  RHA1 upregulates a cluster of 51 genes in response to cholesterol that 
all localize to a 235kb stretch in the chromosome.  These genes encode proteins 
predicted to be involved in !-oxidation, as well as genes with high sequence 
,
identity to enzymes involved in the degradation of steroid rings A and B.  
Interestingly, this cluster is highly homologous to a similar stretch of 82 genes in 
Mtb.  This region, called the Cho region, included genes known to be required for 
Mtb virulence, like hsaC (Yam et al. 2009), igr (Chang et al. 2007) and Mce4 
(Sassetti et al. 2003, Joshi et al. 2006) and strongly suggested that like RHA1, 
Mtb had the ability to metabolize the lipid cholesterol.  
 
Less than a year later, our lab showed that the addition of cholesterol to a 
defined medium that otherwise did not support growth, allowed for Mtb replication 
(Pandey and Sassetti 2008).  This was the first evidence that cholesterol served 
as a carbon source for Mtb growth and also highlighted Mtb’s ability to utilize 
cholesterol for multiple purposes.  By supplementing the defined medium with 
differentially radiolabeled cholesterol, it was demonstrated that the carbon at  
 
 
Figure 1.1 
Cholesterol. Steoid 
rings A-D and 
carbons 1-27 are 
labeled. 
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position 4 (C-4) in steroid ring A was specifically transformed into CO2, while the 
carbon at position 26 in the side chain was specifically incorporated into   
mycobacterial cell wall lipids, including pthiocerol dimycocerosate (PDIM).  The 
transformation of C-4 into CO2 suggested that Mtb was able to metabolize the 
steroid nucleus via the TCA cycle.  Together, this demonstrated that Mtb had the 
ability to utilize the steroid nucleus of cholesterol to generate energy and the side 
chain of cholesterol as a biosynthetic precursor for lipid anabolism.  Pandey and 
Sassetti further demonstrated that cholesterol uptake was mediated by the ABC-
like transport system, Mce4.   
 
The four Mce operons of the Mtb chromosome all share homology to ATPase 
Binding Cassette (ABC) transporters and due to demonstrated genetic 
interactions with lipid metabolism genes were hypothesized to play roles in 
bacterial lipid transport (Casali and Riley 2007, Joshi et al. 2006).  Mce4 encodes 
a ten-gene operon at the beginning of the Cho region.  In the absence of Mce4 or 
the related ATPase, MceG (Joshi et al. 2006), Mtb has a reduced growth rate in 
cholesterol, a decreased rate of cholesterol association, and a slower rate of 14C, 
C-4 conversion to CO2; all of which supports the role of Mce4 in cholesterol 
transport (Pandey et al. 2008).  In addition, the orthologous Mce4 operon in 
RHA1 was shown to be required for growth in, and uptake of, cholesterol (Mohn 
et al. 2008).  The demonstrated involvement of Mce4 in cholesterol utilization had 
additional implications for the role of cholesterol during the course of TB disease.   
%.
 
Mce4 has been shown to be specifically required for virulence during the chronic 
phase of disease in mice; a phenotype that has been recapitulated in bone 
marrow derived macrophages (BMDM) following activation with IFN" (Sassetti et 
al. 2003, Pandey et al. 2008).  This phenotype echoes the phenotype of icl 
mutants and strongly supports the idea that IFN"-induced changes to the 
mycobacterial phagosome during the chronic phase of infection, result in a 
metabolic shift to lipids, specifically cholesterol.  Thus, it appears that Mtb is 
highly adapted to the nutrient limitations of an ever-changing phagosome 
environment. 
 
By studying another operon located within the Cho region, Chang and colleagues 
then demonstrated that cholesterol was being metabolized during the acute 
phase of infection as well (Chang et al. 2009).  The igr locus encodes six genes 
that are upregulated during growth in macrophages, required in vivo during the 
acute phase of a mouse infection and predicted to be involved in cholesterol 
catabolism (Schnappinger et al. 2003, Rengarajan et al. 2005, Sassetti et al. 
2003, Van der Geize et al. 2007, Chang et al. 2007).  Interestingly, some of the 
igr products have been shown to genetically interact with Mce4 and like Mce4, 
these mutants cannot grow on cholesterol as a primary carbon source (Joshi et 
al. 2006, Chang et al. 2009).  In addition, this in vitro attenuation cannot be 
restored by the addition of a supplemental carbon source such as glycerol, 
%%
suggesting that a toxic intermediate of cholesterol catabolism accumulated in igr 
mutants resulting in their subsequent attenuation (Chang et al. 2009).  Moreover, 
Mce4 and igr double knockouts display an almost complete restoration of growth 
in acutely infected mice, indicating that blocking cholesterol uptake inhibited the 
accumulation of the toxic intermediate (Chang et al. 2009).  This important 
finding demonstrates that Mtb metabolizes cholesterol throughout the course of 
infection, but following IFN" activation carbon sources including cholesterol 
become limiting and/or required for survival. 
 
Although cholesterol is clearly an important nutrient in vivo, we knew relatively 
very little about how Mtb utilized this carbon source and the physiological 
adaptations required for metabolizing it.  Specifically, I set out to accomplish the 
following goals: 
 
I. Identify the entire set of bacterial genes required for cholesterol 
utilization. 
II. Further elucidate cholesterol catabolism in Mtb. 
III. Understand the metabolic adaptations of using cholesterol as a 
carbon source. 
IV. Using the Mce systems as a model, understand lipid import in Mtb. 
 
%&
It was obvious that the development of a high-throughput assay was necessary 
to accomplish these goals in a timely and efficient fashion.  By combining recent 
advances in next-generation sequencing technology with existing transposon 
mutagenesis libraries, I was able to make significant contributions to our 
understanding of cholesterol utilization in Mtb. 
 
 
%'
Chapter II. Whole genome phenotypic profiling identifies essential genes in 
Mtb 
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Summary 
The pathways that comprise cellular metabolism are highly interconnected, and 
alterations in individual enzymes can have far-reaching effects.  As a result, 
global profiling methods that measure gene expression are of limited value in 
predicting how the loss of an individual function will affect the cell.  In this 
chapter, we employed a new method of global phenotypic profiling to directly 
define the genes required for the growth of Mtb.  A combination of high-density 
mutagenesis and next-generation sequencing was used to characterize the 
composition of complex mutant libraries exposed to different conditions.  This 
%(
allowed for the unambiguous identification of the genes that are essential for Mtb 
to grow in vitro and proved to be a significant improvement over previous 
microarray approaches.  Specifically, these improvements included increased 
resolution and dynamic range.  Increased resolution allowed for the identification 
of essential genes containing transposon insertions, as well as essential regions 
within genes that correspond to essential functional domains.  In addition, the 
increased dynamic range allowed for the differentiation between genes required 
for growth and optimal growth in Mtb.  Overall the predictions made by both the 
prior microarray and current next-generation sequencing methods are 
functionally similar, but the differences highlight the technical advantages of the 
method described herein. 
 
Introduction 
Mtb is an extremely successful pathogen.  This bacterium must adapt to a number 
of different microenvironments over the course of a chronic infection (Russell et al. 
2010), and understanding the physiological state of the pathogen in these sites is 
central to the design of more effective antitubercular drugs. Defining these 
metabolic adaptations requires a holistic understanding of the cellular pathways that 
are critical for survival in each specific environment. While whole genome methods 
to profile mRNA, protein, or transcription factor binding are valuable for 
understanding cellular responses, gene regulation has proven to be a poor 
predictor of essentiality  (Rengarajan et al. 2005, Badarinarayana et al. 2001). 
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Therefore, genome-wide approaches to accurately and directly assess the relative 
contribution of each gene to the growth and survival of M. tuberculosis are needed. 
 
The genome-scale methods initially used to predict gene essentiality in bacteria 
employed either microarray hybridization (Sassetti et al. 2001, Sassetti et al. 2003,) 
or conventional sequencing (Lamichhane et al. 2003, Jacobs et al. 2003, Hutchison 
III et al. 1999) to map the sites of transposon insertions in large libraries of random 
mutants and identify regions of the chromosome that were unable to sustain 
mutation. Both of these methods suffer from significant limitations.  Microarrays are 
not able to precisely map insertions, resulting in ambiguity regarding the precise 
location of an essential region.  While conventional sequencing can surmount this 
problem, it is both cumbersome and expensive to apply this method to the very 
complex libraries necessary for the unambiguous identification of essential genes. 
Finally, neither of these approaches can be used to quantitatively compare the 
compositions of mutant pools over more than a very small dynamic range. 
 
By employing next-generation sequencing, specifically Illumina sequencing 
technology, these deficiencies were overcome.  Illumina sequencing technology 
allows for massively parallel sequencing of complex samples by using novel 
reversible terminator sequencing chemistry (Ansorge 2009, Turcatti et al. 2008).  
Briefly, libraries of adapter flanking DNA fragments are immobilized on a glass flow 
cell.  Bridge amplification then creates clusters or polonies, of approximately 1000 
%*
identical sequences of a single library-derived fragment.  Sequencing by synthesis 
then occurs by combining four reversible terminator nucleotides each labeled with a 
unique fluorescent dye with a polymerase and a charge-coupled device (CCD) 
camera.  By sequencing clusters of identical molecules the fluorescence intensities 
are increased over other methods.  In addition, the ability to simultaneously 
sequence millions of sequences on the same flow cell drastically reduces the time 
required to sequence complex libraries. 
 
In order to precisely define the genes that are important for the growth of Mtb, 
massively parallel Illumina sequencing technology was used to characterize 
transposon libraries.  This approach achieves single base pair resolution of 
insertion sites in very complex libraries, resulting in the precise identification of 
essential open reading frames.   
 
Materials and Methods 
Mtb growth and selection 
The transposon library was generated in the H37Rv background as previously 
described (cite Sassetti 2001), and consisted of approximately 105 independent 
insertion events. 106 cfu of library were inoculated into 200mls of minimal media 
(asparagine 0.5g/L, KH2PO4 1.0g/L, Na2HPO4 2.5g/L ferric ammonium citrate 
50mg/L, MgSO4 ·7H20 0.5g/L, CaCl2 0.5g/L, ZnSO4 0.1mg/L), 25ug/ml Kanamycin, 
0.2% tyloxapol, 0.2% ethanol and either 0.1% glycerol or 0.01% cholesterol. 
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Selections were carried out in duplicate for glycerol and triplicate for cholesterol. 
Libraries were grown in roller bottles at 37C. Cultures were diluted as necessary to 
maintain the optical density below 0.2. The number of cell generations was 
monitored by cfu enumeration. 
Genomic library preparation 
Genomic DNA was isolated from each library, partially digested with a combination of 
restriction enzymes,, and ligated to asymmetric adapters.  Chromosome transposon 
junctions were amplified as previously described (Sassetti et al. 2001). An additional nested 
PCR was used to incorporate Illumina attachment and sequencing  sites ( 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCTCGGGGACTTATCAGCCAACC and 
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCT
CTTCCGATCTGTCCAGTCTCGCAGATGATAAGG). Standard PCR conditions 
(denaturation at 94°C for 30 seconds, annealing at 57.5°C for 30 seconds and 
amplification at 72°C for 30 seconds) were used and cycled for 9 cycles. 
Amplified fragments between 250-400bp were purified and sequenced using 
either the primer: CCGGGGACTTATCAGCCAACC (complementary to the 
transposon inverted terminal repeat, ITR), or 
ACACTCTTTCCCTACACGACGCTCTTCCGATCT (complementary to the 
Illumina adapter) using an Illumina GA2 instrument. 
Sequence analysis. 
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The Illumina sequencing reads that contained the Himar1 ITR sequence and the 
adjacent TA insertion site were identified in the raw fasta files and trimmed of the 
ITR sequence. The sequences were aligned to the M. tuberculosis H37Rv 
reference genome (Cole et al.1998) using SOAPv1.11 alignment software (Li et 
al. 2008) at default settings (2 mismatches allowed per read). A custom PERL 
script was used to extract the TA dinucleotide insertion site coordinates from the 
SOAP output file (SI Computer Script). For reads aligning to the plus strand of 
the genome, the genome coordinate at position 1 of the trimmed read was 
determined. For reads aligning to the minus strand, the genome coordinate at 
position 2 of the read was calculated to represent the TA coordinate position with 
respect to the plus strand. For each TA insertion site detected by alignment, the 
total number of reads and the strand orientation was determined.  Sequence 
reads that aligned to more than one chromosomal position were randomly 
assigned to one of the positions.  If less than 10% of the reads corresponding to 
an insertion site could be assigned to this single position, the TA site was 
removed from all further analyses.  Insertion site coordinates were mapped to 
positions within protein coding genes annotated in protein table RefSeq file 
NC_000962.ptt (from the National Center for Biotechnology Information: 
ftp://ftp.ncbi.nih.gov/). For each gene, the number of insertion sites identified and 
the total number of sequencing reads in the gene were determined.  
Essential Gene Analysis 
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Genes were scored for essentiality based on the length of the longest contiguous 
run of TA dinucleotide sites lacking observed insertions within the coding region.  
Read counts at each TA site were pooled from both strands and summed over all 
the sequencing runs for each library/growth condition (3 runs for growth on 
glycerol, 2 runs for growth on cholesterol), and sites with 5 or fewer observed 
reads were treated as non-insertions.  The longest consecutive sequence of non-
insertion sites k in each gene was identified.  The expectation for the length of 
the longest run of TA sites lacking insertion in a gene with n TA sites is given by 
the following statistics for a sequence of Bernoulli trials with success probabilty q:  
m=log(1/q)(n(1-q))+g/ln(1/q), s=[p2/(6 ln2(1/ q)+1/12)]-1/2, where g=0.577... is the 
Euler-Mascheroni constant (Schilling, 1990).  In this case, q represents the 
probability of insertions being observed at TA sites in non-essential genes, which 
was estimated based on the total number of TA sites across the genome 
containing insertions divided by the total number of TA sites (excluding those in 
genes completely devoid of insertions between the 5’ 5% and 3’ 20% ends of the 
ORF) in each dataset (q=37,849/63,307=0.598 for glycerol; 
q=35,902/62,888=0.571 for cholesterol).  To assess the statistical significance of 
the observed maximum run of sites without insertions, this was compared to the 
expected length of the longest run using the cumulative function of the Extreme 
Value Distribution to calculate a p-value: p(k;n,m,s)=1-exp(-exp(-(k-m)/s), where 
m and s are the statistics of the expected distribution given above.  
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Results 
Transposon mapping and identification of genes required for Mtb growth in 
vitro 
A library of transposon mutants consisting of approximately 105 independent 
insertion events was generated in the H37Rv strain of Mtb using a modified himar1 
based transposon (Sassetti et al. 2001). Replicate portions of this library were 
expanded for 12 generations in defined media containing different carbon sources, 
and chromosomal DNA was extracted from each pool. This DNA was randomly 
fragmented, ligated to asymmetric adapters, and transposon chromosome junctions 
were amplified using PCR.  Illumina sequencing was then used to determine the 
sequences of 6 to 8 million transposon:chromosome junctions per library.  95-99% 
of these sequences represented the specific amplification of transposon insertions 
(see methods) and were used for subsequent analyses. 
 
The transposon used in these studies requires a TA dinucleotide insertion site.  We 
identified transposon insertions at 44,350 of the 74,605 possible TA sites in the 
genome (Supplemental Table 2.1).  This corresponded to approximately one 
insertion every 100 base pairs on average and was consistent with the previously 
described random insertion of this element (Lamichhane et al. 2003, Rubin et al. 
1999). The identified insertions were distributed throughout the chromosome (Fig. 
2.1A), with the exception of small gaps, many of which corresponded to known 
essential genes in which we expected insertions to be lethal.  For example, a small  
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Figure 2.1 Transposon insertions are randomly distributed, and gaps in 
transposon coverage correspond to predicted essential ORFs.  (A) 
Transposon:chromosome junctions from high density mutant libraries were 
identified by deep sequencing.  The number of sequence reads corresponding to 
each insertion site is represented as green bars mapped onto the circular 
chromosome of M. tuberculosis H37Rv.  Black contour represents the GC 
content of the Mtb chromosome (G+C content greater or less than 50% are 
represented as contours outside or inside the ring, respectively). (B) Essential 
heme biosynthetic genes are devoid of insertions.  The number of sequence 
reads (“reads/TA”) is shown for the indicated region of the H37Rv chromosome.  
Potential TA dinucleotide insertions sites are indicated.  (C) Each potential TA 
insertion site in the genome was assigned a position relative to the nearest ORF.  
The probability of detecting an insertion at each ORF position (per 20 TA 
window) is plotted on the y-axis.  Genes predicted to be nonessential (p=0.9-1.0, 
shown in black) show no position-dependent insertional bias.  In contrast, genes 
predicted to be required for growth with different degrees of confidence (cyan: 
p<0.2, red: p<0.05, blue: p<0.0005) show a strong bias against insertions in the 
open reading frame.  The insertion density at the extreme ends of these ORFs 
approximates that of the nonessential genes.  
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region of the chromosome encodes several of the enzymes required for the 
synthesis of the essential cofactor, heme, (Figure 2.1B) and we found that gaps in 
transposon coverage precisely mapped to these open reading frames (ORFs).   
 
In contrast, we found that other likely essential genes could harbor a small number 
of insertions (not shown), consistent with previous observations (Akerley et al. 
2002).  Therefore, we globally defined essential ORFs by searching for genes with 
statistically significant gaps in transposon insertion coverage, instead of simply 
compiling those that were absolutely devoid of insertions.  To do this, we identified 
the longest sequence of TA sites lacking insertions within a given gene, and 
determined the likelihood of a non-essential gene harboring a gap of that length 
(modeled as a Bernoulli process) as a function of the total number of TA sites in the 
ORF.  We then calculated the probability of the longest observed gap arising by 
chance, relative to the Extreme Value Distribution (Supplemental Table 2.2).  This 
analysis method exploited the value of the high-resolution data provided by deep 
sequencing, while allowing for permissive insertion sites in essential genes.  
 
While the himar1 transposon used in these studies has been shown to integrate 
relatively randomly (Lamichhane et al. 2003, Rubin et al. 1999), it remained 
possible that some regions of the chromosome were resistant to transposition, and 
genes in these regions would erroneously appear to be required for viability.  The 
use of a high-resolution sequencing method allowed us to address this possibility 
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for the first time by determining if the identified gaps in transposon coverage 
corresponded to protein-coding regions.  As shown in Figure 2.1C, the probability of 
identifying a transposon insertion in or near a putative essential region is highly 
correlated with the position of the corresponding predicted ORFs.  In addition, the 
probability of identifying permissive sites within essential genes is higher at the 
extreme 3’ end, likely because these insertions do not fully disrupt gene function.  
Together, these data indicate that regions devoid of sequenced transposon 
insertions represent protein-coding genes that are important for the growth or 
survival of the organism and not regions that are less accessible to transposition. 
 
Comparison with previous studies 
This deep sequencing-based approach for identifying growth-attenuated mutants 
both validates and improves upon our previous microarray-based studies.  About 
15% of the Mtb genome or 614 genes, were previously predicted to be required for 
optimal growth in vitro using microarray hybridization to map insertions sites 
(Sassetti et al. 2003).  Using a p value cutoff of 0.05, our current deep sequencing 
approach predicts a similar number of 620 essential genes.  These gene sets 
overlap to a large extent and encode a similar distribution of cellular functions, 
which are quite different from the genome as a whole (Fig. 2.2A, 2.2B).   
 
Despite the gross similarities between the two gene sets, we also found differences 
(Fig. 2.2A, 2.2C).  While some of these differences may be attributable to minor  
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Figure 2.2 Defining essential genes with deep sequencing is more sensitive 
and precise than previous approaches. (A) Genes predicted to be essential 
via microarray (left) are compared with genes predicted to be essential via deep 
sequencing (right).  Our false discovery rate allowed us to make confident 
predictions regarding essentiality for genes with more than 7 TAs. Thus, genes 
with fewer TAs were removed from this analysis. (B) Microarray and deep 
sequencing identify essential genes sets consisting of similar predicted functions, 
which differ from the genome as a whole.  COG functions associated with 
essential genes predicted by microarray (Sassetti et al. 2003) or deep 
sequencing are plotted along with the predictions for the entire genome. COG 
functions are: 1) Translation, ribosomal structure, biogenesis, 2) RNA 
processing, modification, 3) Transcription, 4) Replication, recombination, repair, 
5) Cell cycle control, cell division, chromosome partitioning, 6) Defense 
mechanisms, 7) Signal transduction mechanisms, 8) Cell 
wall/membrane/envelope biogenesis, 9) Cell motility, 10) Intracellular trafficking, 
secretion, vesicular transport, 11) Posttranslational modification, protein turnover, 
chaperones, 12) Energy production, conversion, 13) Carbohydrate transport, 
metabolism, 14) Amino acid transport, metabolism, 15) Nucleotide transport, 
metabolism, 16) Coenzyme transport, metabolism, 17) Lipid transport, 
metabolism, 18) Inorganic ion transport, metabolism, 19) Secondary metabolites 
biosynthesis, transport, catabolism, 20) General function prediction only, 21) 
Function unknown, 22) No assignment.  
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Figure 2.2 Defining essential genes with deep sequencing is more sensitive 
and precise than previous approaches. (C) Microarray predictions are 
generally, but not absolutely, consistent with deep sequencing. The probability of 
essentiality defined via deep sequencing is plotted on the x-axis (as log p value) 
for genes previously predicted by microarray to be either essential (black) or 
nonessential (gray). (D) Mutations in nonessential genes previously predicted to 
be required for growth cause quantitative fitness defects. Normalized sequence 
reads per gene (log scale) are plotted for all genes (black) and genes predicted 
to be essential by microarray (gray).  Previously defined essential genes with 
detectable insertions are associated with low sequence read counts, suggestive 
of quantitative underrepresentation in the library. 
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alterations in the growth media used in these studies, it is likely that most 
discrepancies are due to both the increased resolution and dynamic range of the 
current method.  For example, approximately one half of the genes that deep 
sequencing identified as essential (p < .05) could sustain a small number of 
insertions (Fig. 2.1C and Supplemental Table 2.2).  The presence of these 
permissive insertion sites likely caused many of these genes to be deemed 
nonessential by lower resolution methods.   
 
The second major difference between these datasets is a result of the sequencing 
depth that was employed.  Because of the limited dynamic range of the microarray 
method (typically 3-10 fold), it was difficult to differentiate between mutants that 
were truly nonviable and those that were merely significantly underrepresented. 
The increased dynamic range of deep sequencing-based mapping allowed for this 
differentiation.  Indeed, the insertions we identified in genes previously predicted to 
be essential were associated with a significantly lower number of sequence reads 
than the genome as a whole (Fig. 2.2D).  This suggested that these mutants 
suffered from a fitness defect but remained viable.  Based on the average number 
of sequence reads we detected in nonessential regions (173), we estimate that 
genes containing statistically significant gaps in coverage correspond to mutants 
that are more than 100 fold underrepresented in the pool, and are therefore 
essentially nonviable. 
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Investigating essentiality at the subgenic level 
The increased resolution of Illumina sequencing also allowed the identification of 
essential regions at the subgenic level.  Microarray hybridization only probed one 
segment of each ORF.  In contrast, by direct sequencing we individually probed the 
effects of insertions every 100 bp on average, and found several examples of 
differential phenotypes caused by mutations in the same gene.  For example, two of 
the eleven Ser/Thr kinases (Cole et al. 1998, Av-Gay and Everett 2000) of Mtb, 
PknA and PknB, are encoded in the same operon with the only known phospho-
Ser/Thr phosphatase, PstP (Figure 2.3).  All three of these genes have been 
predicted or demonstrated to be essential for viability.  This high-resolution data 
verifies that both of the kinases are required for in vitro growth, and that neither the 
intracellular kinase domain nor the extracellular sensor domains of PknB can 
sustain insertions.   
 
In contrast, only the region of the pstP gene encoding the predicted cytosolic 
phosphatase domain was devoid of transposon insertions, despite the presence of 
11 TA sites.  Unlike the phosphatase domain, mutations were tolerated throughout 
the regions of the pstP ORF encoding the C-terminal transmembrane and 
extracellular domains (Figure 2.3).  The absence of transposon insertions in the 
phosphatase domain could not be explained by chance alone, as the probability of 
not detecting an insertion in 11 contiguous nonessential TAs is less than 10-6.  
Similarly but somewhat paradoxically, the Rv0020c gene was disrupted throughout 
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its 5’ end but could not sustain insertions in the 3’ domain that encodes a 
phosphothreonine-binding forkhead-associated domain.  Thus, it appears that 
insertions disrupting distinct protein domains may have different effects on growth, 
and these phenotypes can be distinguished in the whole-genome dataset. 
 
 
Figure 2.3 Illumina sequencing predicts subgenic essentiality.  
Arrows indicate sequenced transposon insertions.  While both pknB and pknA 
are completely devoid of sequenced insertions, pstP is devoid of insertions only 
throughout a predicted phosphatase domain indicating its functionally required.  
 
 
Similar phenotypes can be observed in a unique Mtb locus encoding a lipid II 
flippase protein, flpA (Gee et al. 2011).  When the flpA locus was examined in 
detail, we found that transposon insertions are not tolerated in the 1728 basepair 
region homologous to flippase-like MviN genes or in the upstream gene, Rv3909 
(Figure 2.4).  However, 3’ to the MviN-like region, insertions were detected in 65% 
of the TA insertion, which is approximately the same density as the genome as a 
whole.  This distribution suggested that the MviN-like domain is essential for 
viability, and the C-terminal domains are less important for in vitro growth.  Gee and 
colleagues confirm this observation by probing this region by allelic exchange 
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mutagenesis, proving that differential phenotypes observed using whole-genome 
phenotypic profiling accurately predicts essential subgenic domains (Figure 2.5). 
 
 
 
Figure 2.4 Illumina sequencing identifies an essential MviN domain in FlpA. 
Transposon insertion mapping in Mtb indicates that the MviN domain of FlpA is 
essential for viability. The 28 TA sites in the MviN domain were devoid of 
insertions, indicating that disruption of this domain produced nonviable mutants. 
The probability of this distribution occurring by chance in a gene of this size is 
<10-6. Insertions in the regulatory domains of flpA were found at a similar density 
as the rest of the genome (65% of TA sites). “TN::576” indicates the amino acid 
position of the first detected transposon insertion.  
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Figure 2.5 Homologous recombination validates subgenic essentiality. 
Homologous recombination confirms the differential essentiality of FlpA domains. 
Progressive deletions from the 3’ end of the Mtb flpA gene were generated using 
the mycobacteriophage che9c recombination system. Deletions removing any 
transmembrane segments in the MviN-like module (red residue numbers) were not 
obtained. Deletions were isolated within the sensor kinase-like module (green 
residue numbers). The number of deletion mutants identified over the total number 
of hygr colonies obtained following transformation with linear recombineering 
substrates is indicated. 
 
Discussion 
In this work, we have significantly refined our understanding of the cellular functions 
necessary for the viability of Mtb.  While others have used similar deep sequencing 
methods to map insertion sites in other organisms (Gawronski et al. 2009, 
Goodman et al. 2009, Langridge et al. 2009, van Opijnen et al. 2009, Gallagher et 
al. 2010) our new analytical tools allowed the statistically rigorous prediction of the 
genes essential for the viability of Mtb. The majority of these essential genes are 
consistent with those found by previous microarray-based methods. However, very 
significant differences in these predictions were also noted, and the majority of 
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these are attributable to technical and analytical refinements.  As a result, this work 
provides a much more precise and statistically rigorous assessment of essentiality 
than previously possible. 
 
The advantages of this method are apparent in the data generated.  The ability to 
identify essential genes containing insertions allowed for the refinement of the 
definition of an essential gene.  In addition, the increased resolution also allowed for 
the analysis of subgenic essentiality.  The power of this method was demonstrated 
here in two Mtb loci.  Larger scale analysis of this type would require more 
functional domains to be described and mapped, as well as non-coding RNAs.  It 
also requires several assumptions regarding the transposon and expression of the 
downstream chromosome.  For example, it is likely that the strong promoter 
controlling expression of the Kanamycin resistance cassette within the transposon 
is also driving transcription through the transposon:chromosome junction.  Effective 
expression would also require a functional translational start site and possibly a 
ribosome binding site after the end of the transposon, which containes 2 
translational stop sites.  In addition, it certainly requires an absence of polarity 
resulting from transposition events.  Our data and others’ supports this claim 
(Sassetti et al. 2001).  In particular, insertions upstream of essential genes, pknA 
and pknB are tolerated indicating the absence of polar effects associated with this 
transposon. 
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As with any whole-genome profiling method, this method is bound by its limitations.  
While Illumina sequencing is becoming more routine and less costly than traditional 
Sanger sequencing, it remains out of reach for some.  This cost can be reduced by 
either engineering unique transposons or modifying amplified libraries with 
barcodes, or signature sequences, that identify them from other libraries.  Either of 
these modifications would allow multiple libraries to be run in the same lane of a 
flow cell, significantly decreasing the cost associated with high-throughput 
sequencing.  In addition to cost, bias can be introduced during PCR amplification of 
output libraries.  Current efforts are underway to implement emulsion based PCR to 
reduce this bias.  Similar to other next-generation sequencing techniques, emulsion 
PCR allows the amplification of a single template in an oil droplet within a liquid 
phase.  This decreases bias, as each template is not in competition with other 
templates for nucleotides, enzyme or cofactors. 
 
It is likely that as high-throughput sequencing technologies continue to emerge and 
improve, further applications of this method will arise.  The increased dynamic 
range of the current method not only allowed for the identification of mutants with 
reduced fitness in vitro, but also the identification of mutants required in various 
conditions.  By using the abundance of each mutant as an indicator for relative 
fitness, the next chapter focuses on using this method to identify genes required for 
growth in cholesterol, a critical carbon source in vivo. 
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Chapter III: Whole genome phenotypic profiling identifies the entire set of 
genes required for utilizing cholesterol 
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Summary 
To explore functions that are required for cholesterol utilization, a combination of 
high-density mutagenesis and Illumina sequencing was used to characterize the 
composition of complex mutant libraries grown on different carbon sources, 
including cholesterol.  The cellular pathways specifically required for cholesterol 
utilization were then defined.  Few of the genes we identified had previously been 
implicated in this adaptation by transcriptional profiling, and only a fraction was 
encoded in the chromosomal region known to encode sterol catabolic functions.  
These genes could be assigned to distinct steps in cholesterol utilization, and 
comprise an unexpectedly large percentage of genes previously shown to be 
required for bacterial growth in mouse tissue.  The nutritional adaptation to 
cholesterol by Mtb accounts for a significant fraction of the adaption to the host. 
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This work provides the first comprehensive characterization of a sterol catabolic 
pathway and suggests putative roles for uncharacterized virulence genes. 
 
Introduction 
Despite work from our lab and others identifying cholesterol as an important carbon 
source during chronic Mtb infection (Pandey and Sassetti 2008, Van der Geize et 
al. 2007), the cholesterol catabolic pathway remained to be clearly defined.  Much 
of the Cho region was predicted to encode enzymes with functions in cholesterol 
catabolism and yet, only a handful of those had been demonstrated in vitro to 
catalyze their predicted reactions (Yang et al. 2007, Capyk et al. 2009, Dresen et al. 
2010, Yam et al. 2009, Lack et al. 2010, Ouellet et al. 2010, Nesbitt et al. 2010).  
Moreover, of the genes encoding these enzymes, few had demonstrated 
phenotypes either in vitro or in vivo (Nesbitt et al. 2010, Yam et al. 2009, Chang et 
al. 2007, Hu et al. 2010).   
 
Cholesterol catabolism is better defined in the related actinomycete, Rhodococcus 
strain RHA1, where it occurs in two simultaneous phases; !-oxidation of the side 
chain and sterol ring cleavage and opening of the steroid nucleus (Van der Geize et 
al. 2007).  It is currently unclear which pathway begins cholesterol catabolism in 
Mtb, though it is likely started with the oxidation of cholesterol to choles-4-en-3-one, 
a reaction mediated in other organisms by both cholesterol oxidases and 
dehydrogenases.  Mtb encodes both a cholesterol oxidase, ChoD, and a 3!- 
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hydroxysteroid dehydrogenase, Rv1106c, and both have been predicted to be 
responsible for this obligatory first step (Brzostek et al. 2007, Yang et al. 2007).  
 
The cytochrome P450, Cyp125, initiates side-chain degradation in RHA1 by 
mediating the oxidation of carbon at position 26 to the subsequent carboxylic acid 
(Rosloniec et al. 2009).  Paradoxically, the orthologous Cyp125 is required for 
growth in cholesterol for M. bovis and Mtb strain CDC1551, but not for the Mtb lab 
strain H37Rv (Capyk et al. 2009, Ouellet et al. 2010, Johnston et al. 2010). 
However, Johnston and colleagues have recently shown that Cyp125 and an 
additional cytochrome P450, Cyp142 are functionally redundant.  It remained 
unclear which steroid monooxygenase was required for cholesterol catabolism in 
Mtb H37Rv.  
 
The depth of sequencing provided by Illumina technology allowed for the relative 
abundance of individual mutants to be accurately assessed, enabling the 
quantitative comparison of libraries grown under different conditions.  Using this 
approach, genes required for growth in cholesterol were defined as genes that were 
significantly underrepresented in the cholesterol pool relative to the glycerol pool. 
This analysis identified genes involved in both cholesterol catabolism and the 
metabolism of the resulting metabolites.  
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In addition to identifying the cholesterol catabolic pathway in Mtb, this chapter 
serves as an introduction into the metabolic adaptations to growth on cholesterol, 
which are further investigated in chapter IV.   
 
Materials and Methods 
Mtb growth and selection 
The transposon library was generated in the H37Rv background as previously 
described (cite Sassetti 2001), and consisted of approximately 105 independent 
insertion events. 106 cfu of library were inoculated into 200mls of minimal media 
(asparagine 0.5g/L, KH2PO4 1.0g/L, Na2HPO4 2.5g/L ferric ammonium citrate 
50mg/L, MgSO4 ·7H20 0.5g/L, CaCl2 0.5g/L, ZnSO4 0.1mg/L), 25ug/ml Kanamycin, 
0.2% tyloxapol, 0.2% ethanol and either 0.1% glycerol or 0.01% cholesterol. 
Selections were carried out in duplicate for glycerol and triplicate for cholesterol. 
Libraries were grown in roller bottles at 37C. Cultures were diluted as necessary to 
maintain the optical density below 0.2. The number of cell generations was 
monitored by cfu enumeration. 
Genomic library preparation 
Genomic DNA was isolated from each library, partially digested with a combination of 
restriction enzymes,, and ligated to asymmetric adapters.  Chromosome transposon 
junctions were amplified as previously described (Sassetti et al. 2001). An additional nested 
PCR was used to incorporate Illumina attachment and sequencing  sites ( 
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AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCTCGGGGACTTATCAGCCAACC and 
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCT
CTTCCGATCTGTCCAGTCTCGCAGATGATAAGG). Standard PCR conditions 
(denaturation at 94°C for 30 seconds, annealing at 57.5°C for 30 seconds and 
amplification at 72°C for 30 seconds) were used and cycled for 9 cycles. 
Amplified fragments between 250-400bp were purified and sequenced using 
either the primer: CCGGGGACTTATCAGCCAACC (complementary to the 
transposon inverted terminal repeat, ITR), or 
ACACTCTTTCCCTACACGACGCTCTTCCGATCT (complementary to the 
Illumina adapter) using an Illumina GA2 instrument. 
Sequence analysis. 
The Illumina sequencing reads that contained the Himar1 ITR sequence and the 
adjacent TA insertion site were identified in the raw fasta files and trimmed of the 
ITR sequence. The sequences were aligned to the M. tuberculosis H37Rv 
reference genome (Cole et al.1998) using SOAPv1.11 alignment software (Li et 
al. 2008) at default settings (2 mismatches allowed per read). A custom PERL 
script was used to extract the TA dinucleotide insertion site coordinates from the 
SOAP output file (SI Computer Script). For reads aligning to the plus strand of 
the genome, the genome coordinate at position 1 of the trimmed read was 
determined. For reads aligning to the minus strand, the genome coordinate at 
position 2 of the read was calculated to represent the TA coordinate position with 
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respect to the plus strand. For each TA insertion site detected by alignment, the 
total number of reads and the strand orientation was determined.  Sequence 
reads that aligned to more than one chromosomal position were randomly 
assigned to one of the positions.  If less than 10% of the reads corresponding to 
an insertion site could be assigned to this single position, the TA site was 
removed from all further analyses.  Insertion site coordinates were mapped to 
positions within protein coding genes annotated in protein table RefSeq file 
NC_000962.ptt (from the National Center for Biotechnology Information: 
ftp://ftp.ncbi.nih.gov/). For each gene, the number of insertion sites identified and 
the total number of sequencing reads in the gene were determined.  
Differential Growth Analysis 
Samples were normalized such that the mean number of sequence reads per 
insertion site was equal.  The relative representation of each mutant was 
determined by calculating the fold change (sequence reads/insertion in cholesterol 
divided by sequence reads/insertion in glycerol) for each gene.  Statistical 
significance was determined by T test.  Data sets used for comparison consisted of 
each normalized sequence read value within a given gene (each insertion site in 
each sample was treated as a separate data point).  The hyperbola used for 
defining genes specifically required for growth in cholesterol was defined by the 
formula, y=3.8/x+0.7. Genes above this line are annotated as required for growth 
on cholesterol in Table 3.1. 
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Results 
Genes specifically required for growth on cholesterol  
Illumina sequencing provided a rapid, accurate, and quantifiable assessment of the 
composition of mutant libraries, indicating that the quantitative comparison of 
mutant pools selected under different conditions should be possible.  We compared 
pools grown in glycerol, a standard in vitro carbon source, or cholesterol, a critical 
carbon source during infection (Pandey et al. 2008), in order to define the discrete 
genes and pathways required for the catabolism of cholesterol. 
 
In principle, the number of sequence reads associated with a specific insertion 
should be proportional to the relative abundance of the corresponding mutant in the 
library.  We predicted that the sequencing depth used in our study would allow the 
relative abundance of each mutant in different libraries to be compared over a 100-
1000 fold dynamic range.  To verify this prediction, we specifically analyzed the 
genes encoding the previously characterized cholesterol uptake system encoded by 
the ten-gene mce4 operon.  Disruption of Mce4 function by deleting an essential 
transmembrane component has been shown to cause specific defects in 
cholesterol uptake and growth in this carbon source (Pandey et al. 2008).  
Consistent with these observations, we found that mutations in every gene of this 
operon, as well as the associated ATPase (Joshi et al. 2006), resulted in severely 
impaired growth in cholesterol relative to glycerol (Fig 3.1A).  The degree of this 
selective underrepresentation predicted that these mutants suffered a 31% growth  
(.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Defining genes that are specifically required for growth on 
cholesterol. (A) Mce4 mutants are specifically underrepresented in the 
cholesterol-grown pool. Transposon libraries grown for 12 generations in media 
with either glycerol or cholesterol as a primary carbon source were compared by 
deep sequencing. Normalized sequence reads for individual insertions sites 
throughout the Mce4 operon are shown following growth in glycerol (blue) and 
cholesterol (red). The average underrepresentation of Mce4 mutants in the 
cholesterol-grown pool corresponds to a predicted 31% growth defect.  (B) The 
number of sequence reads per TA provides an accurate estimate of relative 
growth rates.  The experimentally determined growth curves of a Mce4 deletion 
mutant in the indicated media are compared to the growth rate of Mce4 mutants 
predicted in panel A.  Log phase growth is plotted as percentage of initial 
bacterial number.   
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disadvantage per generation, which is very similar to the experimentally observed 
doubling time of an isolated Mce4 mutant in these media (Fig. 3.1B).  In addition, 
growth curves for 3 additional transposon mutants were experimentally verified and 
found to correlate with their predicted phenotypes in each culture condition (Fig. 
3.1C).  Thus, the number of sequence reads associated with a given mutant could 
be used to accurately estimate relative growth rate.   
  
Using the number of sequence reads per insertion site as an estimate of relative 
abundance, we compared the genome-wide data sets.  As expected, we found that 
the representation of most mutants was similar in both pools (Fig. 3.1D). Due to the 
pre-selection of the library on complex glycerol-containing media before passage in 
single carbon sources, relatively few mutants were found to be specifically required 
for growth in glycerol. In contrast, a much larger number of mutants were 
underrepresented in the cholesterol-grown pool.  To define differentially 
represented mutants, we employed a cutoff using a continuous function that equally 
weighted statistical significance and the magnitude of the change in representation 
(Fig. 3.1D). 96 genes met these criteria and were therefore predicted to be 
important for growth on cholesterol (Table 3.1 and Supplemental Table 3.1).  
 
While the cholesterol catabolic pathway of Mtb has only been partially defined, all of 
the known and predicted catabolic enzymes are encoded in a distinct ~50kb region.  
This “Cho region” comprises over 80 genes and includes the mce4 operon (Van der 
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Figure 3.1 Defining genes that are specifically required for growth on 
cholesterol. (C) Mutants predicted to be required for cholesterol utilization display 
a specific growth defect in this media.  Transposon insertion mutants were grown in 
minimal media with the indicated primary carbon sources and the rate of growth 
during log phase in each condition was plotted.  (D) Identification of genes that are 
differentially required for growth.  For each gene, the ratio of normalized sequence 
reads per insertion site (cholesterol pool/glycerol pool) is plotted on the x-axis (“fold 
change”).  Y-axis represents the significance of each of these changes in 
representation (p value).  A hyperbolic function was used to define genes that were 
differentially represented.  The asymptotes of these curves are 0 for the log2 fold 
change and -0.07 for the log10 p value.  Genes containing fewer than 2 TA sites 
were excluded from the analysis. Genes in blue represent those within the 
predicted cholesterol region.  
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Geize et al. 2007; Nesbitt et al. 2010).  While the genes we found to be required for 
growth in cholesterol were enriched in this region, the majority (>60%) were 
distributed throughout the chromosome (Fig. 3.1D).  These genes encoded a wide 
variety of predicted enzymatic activities that could be categorized into the following 
three functional groups associated with cholesterol utilization.  
 
Sterol ring degradation 
Following import, cholesterol is degraded via !-oxidation of the side-chain, and ring 
cleavage to open the steroid nucleus (Fig. 3.2).  Our phenotypic data supports and 
augments the current predicted pathway for sterol ring degradation.  The first step 
in cholesterol catabolism requires the oxidation of the 3!-hydroxyl group and 
isomerization of the resulting cholest-5-en-3-one to cholest-4-en-3-one. Two distinct 
enzymes have been suggested to be involved in this transformation; a 
hydroxysteroid dehydrogenase, Rv1106c, and a cholesterol oxidase, ChoD (Yang 
et al. 2007, Brzostek et al. 2007). We found that only mutations in the ketosteroid 
dehydrogenase gene caused a significant growth defect, whereas choD mutants 
appeared to grow at a similar rate in both carbon sources (Fig. 3.2A, and 
Supplemental Table 3.1).  
 
While all of the subsequent predicted steps of sterol ring degradation were critical 
for growth in cholesterol, the degree of importance varied depending on the position 
of the enzyme in the pathway.  We found that hsaEFG mutants, which are predicted  
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Figure 3.2 Phenotypic profiling predicts the cholesterol catabolic pathway. 
Proposed chemical transformations necessary for cholesterol degradation are 
divided into sterol ring cleavage and opening (A) and side-chain degradation (B).  
Enzymes known to or predicted to function at each step are noted with their 
respective fold change (sequence reads in cholesterol/sequence reads in 
glycerol) below. Dotted lines represent spontaneous reactions. We did not find 
enzymes with marked * to be significantly required for growth on cholesterol. 
Enzymes marked with ** indicate those where we are unable to report 
significance due to insufficient data. The specific -oxidation steps mediated by 
fadE28 and fadE29 are difficult to predict based on their homology to 
testosterone degrading enzymes and therefore, we have assigned them to both 
equally likely steps.   
()
to be unable to further degrade 2-hydroxyhexa-2,4-dieneoic acid (HHD) to 
propionate and pyruvate, were only modestly defective in cholesterol media, in 
contrast to the drastic growth attenuation of mutants lacking functions at earlier 
steps.  This is likely because HsaEFG act distal to a branchpoint in the pathway 
and the mutant bacteria could grow, albeit slowly, by fully catabolizing the portion of 
the molecule containing rings C and D.   
 
Side-chain degradation 
In the related actinomycete, Rhodococcus jostii RHA1, the initial hydroxylation of 
C26 during side-chain degradation is mediated by the cytochrome P450 encoded 
by the cyp125 gene (Rosloniec et al. 2009). In Mtb, the Cyp125 ortholog serves a 
similar function (Capyk et al. 2009, Ouellet et al. 2010), although Cyp142 has been 
shown to serve a functionally redundant role (Johnston et al. 2010).  Here, we 
identify Cyp125 as the sole monooxygenase significantly required for growth on 
cholesterol (Table 3.1 and Supplemental Table 3.1). However, the modest 5.5 fold 
underrepresentation of cyp125 mutants in cholesterol supports the previously 
observed redundancy between cytochrome P450 enzymes.  
 
Many enzymes resembling those predicted to be required for the !-oxidation of the 
cholesterol side-chain are encoded in the Cho region.  Surprisingly, we found 
significant functional clustering even within this region.  None of the predicted !-
oxidation genes encoded within the first half of the Cho region were required for  
(*
Table 3.1  Genes predicted to be specifically required for growth on 
cholesterol. 
 
    Ratio   
Locus synonym glycerol/cholesterol p value 
Rv0009 ppiA 0.269 0.003 
Rv0153c ptbB 0.023 0.053 
Rv0202c mmpL11 0.122 0.001 
Rv0244c fadE5 0.133 0.000 
Rv0362 mgtE 0.005 0.000 
Rv0391 metZ 0.073 0.000 
Rv0450c mmpL4 0.210 0.000 
Rv0485 - 0.020 0.000 
Rv0495c - 0.081 0.002 
Rv0655 mkl 0.149 0.001 
Rv0693 pqqE 0.062 0.002 
Rv0694 lldD1 0.058 0.007 
Rv0695 - 0.147 0.011 
Rv0696 - 0.062 0.015 
Rv0761c adhB 0.051 0.006 
Rv0805 - 0.105 0.007 
Rv0876c - 0.421 0.001 
Rv1071c echA9 0.347 0.003 
Rv1084 - 0.428 0.001 
Rv1096 - 0.120 0.006 
Rv1129c - 0.015 0.000 
Rv1130 - 0.013 0.000 
Rv1131 gltA1 0.056 0.005 
Rv1183 mmpL10 0.149 0.000 
Rv1193 fadD36 0.064 0.006 
Rv1428c - 0.124 0.000 
Rv1432 - 0.023 0.009 
Rv1608c bcpB 0.145 0.006 
Rv1626 - 0.014 0.000 
Rv1627c - 0.085 0.000 
Rv1798 - 0.056 0.003 
Rv1906c - 0.062 0.010 
Rv1919c - 0.194 0.006 
Rv1963c mce3R 0.057 0.000 
Rv2048c pks12 0.152 0.000 
Rv2118c - 0.323 0.001 
Rv2206 - 0.013 0.033 
Rv2239c - 0.015 0.029 
Rv2416c eis 0.396 0.001 
(+
Rv2462c tig 0.260 0.000 
Rv2506 - 0.233 0.000 
Rv2668 - 0.205 0.001 
Rv2681 - 0.571 0.000 
Rv2684 arsA 0.073 0.000 
Rv2710 sigB 0.132 0.004 
Rv2799 - 0.262 0.001 
Rv2914c pknI 0.437 0.000 
Rv2985 mutT1 0.334 0.002 
Rv3050c - 0.026 0.055 
Rv3274c fadE25 0.268 0.001 
Rv3419c gcp 0.032 0.029 
Rv3421c - 0.052 0.042 
Rv3492c - 0.027 0.004 
Rv3493c - 0.015 0.001 
Rv3494c mce4F 0.007 0.000 
Rv3495c lprN 0.045 0.001 
Rv3496c mce4D 0.043 0.000 
Rv3497c mce4C 0.045 0.000 
Rv3498c mce4B 0.060 0.001 
Rv3499c mce4A 0.044 0.000 
Rv3500c yrbE4B 0.016 0.000 
Rv3501c yrbE4A 0.009 0.000 
Rv3502c fabG 0.004 0.000 
Rv3515c fadD19 0.268 0.000 
Rv3526 kshA 0.006 0.000 
Rv3531c - 0.279 0.000 
Rv3534c hsaF 0.225 0.003 
Rv3536c hsaE 0.202 0.005 
Rv3537 kstD 0.109 0.000 
Rv3540c ltp2 0.015 0.001 
Rv3542c - 0.054 0.002 
Rv3543c fadE29 0.023 0.004 
Rv3544c fadE28 0.006 0.000 
Rv3545c cyp125 0.269 0.000 
Rv3546 fadA5 0.040 0.000 
Rv3548c - 0.010 0.000 
Rv3549c - 0.004 0.000 
Rv3551 - 0.007 0.000 
Rv3553 - 0.021 0.000 
Rv3559c - 0.016 0.037 
Rv3560c fadE30 0.006 0.000 
Rv3561 fadD3 0.218 0.001 
Rv3563 fadE32 0.096 0.000 
(,
Rv3564 fadE33 0.021 0.020 
Rv3568c hsaC 0.011 0.001 
Rv3569c hsaD 0.023 0.000 
Rv3570c hsaA 0.067 0.004 
Rv3571 kshB 0.008 0.000 
Rv3572 - 0.392 0.002 
Rv3573c fadE34 0.245 0.006 
Rv3575c - 0.234 0.000 
Rv3779 - 0.403 0.001 
Rv3820c papa2 0.376 0.000 
Rv3824c papa1 0.431 0.000 
Rv3825c pks2 0.400 0.000 
Rv3911 sigM 0.258 0.003 
“Ratio glycerol/cholesterol” = mean of sequence reads per detected insertion in 
cholesterol pools / mean of sequence reads per detected insertion in glycerol 
pools 
“p value” = significant of the ratio measurement. Determined as described in 
materials and methods. 
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growth on cholesterol, except hsd4A (Supplementary Table 3.1).  Instead, we found 
that almost all of those encoded in the second half were required (including ltp2, 
fadE29, fadE28, fadA5, fadE30, FadE32, fadE33, fadE34, and hsd4B).  Notably, we 
also identified predicted !-oxidation genes encoded outside of the Cho region that 
had not yet been implicated in cholesterol degradation (including fadE5, echA9, 
fadD36, and fadE25) (Figure 3.2B). Together, these genes could perform the three 
rounds of !-oxidation predicted to be required for full catabolism of the C17 side-
chain, although we cannot exclude the participation of other functionally-redundant 
enzymes, or the possibility that some of these genes participate in degradation of 
the steroid nucleus.   
 
Intermediary metabolism 
Cholesterol catabolism is thought to result in the production of an unusual mixture 
of metabolites including the C2 unit acetyl CoA, the C3 unit propionyl CoA, and 
pyruvate (Pandey et al. 2008, Van der Geize et al. 2007, Yang et al. 2009). Under 
the conditions used in our study, incorporation of propionyl CoA into the TCA cycle 
of Mtb requires the activity of the methylcitrate cycle (MCC) (Gould et al. 2006). 
Consistent with these predictions, prpD, prpC mutants lacking the dedicated steps 
in the MCC were defective for growth in cholesterol (Supplemental Table 3.1).  
The isocitrate lyase gene product (Icl) functions both in the MCC and in a more 
traditional role in the anapleurotic glyoxylate bypass, by converting isocitrate to 
succinate and glyoxylate during growth on C2-generating substrates (Gould et al. 
).
2006). We found icl mutants to be 125-fold underrepresented in the cholesterol-
grown pool (Supplemental Table 3.1), verifying an important functional role.  In 
addition, our data suggests that the expression of this multifunctional enzyme may 
be rate limiting during growth on cholesterol, as the mutation of RamB, a negative 
regulator of icl expression (Micklinghoff et al. 2009), resulted in the opposite effect 
(a nine-fold overrepresentation in the cholesterol-grown pool).  
 
Growth on lipids as a primary carbon source requires gluconeogenesis, and 
different metabolites can be used to fuel this pathway.  Following growth on 
cholesterol, we found that ppdK mutants were severely underrepresented 
(Supplemental Table 3.1). This gene encodes pyruvate phosphate dikinase, which 
can mediate the conversion of pyruvate to phosphoenolpyruvate (PEP), the first 
committed step of gluconeogenesis. Together, these observations define discrete 
pathways required for the assimilation of all three of the metabolites that most likely 
result from cholesterol catabolism. These include the MCC, the glyoxylate bypass 
and PpdK-mediated gluconeogenesis. 
 
Discussion 
In addition to the qualitative analysis in chapter II, here quantitative analysis is used 
to compare mutant pools grown in different carbon sources in order to understand 
how Mtb metabolizes cholesterol.  A number of recent studies have demonstrated 
that Mtb mutants lacking the capacity to acquire or degrade cholesterol are 
)%
defective for growth in animal models of TB (Chang et al. 2009, Hu et al. 2010, 
Nesbitt et al. 2007, Pandey et al. 2008, Yam et al. 2009). However, our ignorance 
of the pathways required for cholesterol metabolism limited our ability to assess the 
importance of this nutritional adaptation during infection.  In order to define a 
discrete set of the predicted 3987 ORFs in Mtb that was required for growth on 
cholesterol, we applied a continuous function cutoff to our comparative data, which 
placed equal importance on fold change in representation and statistical 
significance. More traditional one-dimensional cutoffs would have excluded genes 
that were only moderately underrepresented but exceptionally significant, which our 
analysis includes. Nonetheless, in order to avoid false positive predictions, we set a 
relatively stringent cutoff, and it is likely that even more than the 96 identified genes 
contribute to growth in cholesterol.  
 
In addition to the dedicated cholesterol catabolic functions, we found that the use of 
this compound as a source of both cellular energy and biosynthetic carbon requires 
a variety of central metabolic pathways.  While some of these requirements might 
have been predicted based on the shift from a glycolytic substrate to one that relies 
heavily on !-oxidation, the precise pathways utilized appear specific to the unusual 
mixture of metabolites derived from cholesterol.  For example, gluconeogenesis 
under these conditions appears to be initiated by the conversion of pyruvate to PEP 
via the action of pyruvate phosphate dikinase (PpdK), whereas this pathway relies 
exclusively on phosphenolpyruvate carboxykinase (PckA) during growth on acetate 
)&
(Marrero et al. 2010).  In other bacteria, PpdK-mediated gluconeogensis is favored 
during growth in the presence of pyruvate (Benziman et al.1971; Østerás et 
al.1997). As pyruvate is produced both as a direct product of sterol catabolism and 
through the activity of the methylcitrate cycle, we speculate that the relative 
abundance of cholesterol-derived pyruvate favors the PpdK-mediated pathway.  
These observations indicate that different gluconeogenic pathways may be 
preferentially used by Mtb depending on the relative abundance of precursor 
metabolites.   
 
Cholesterol acquisition is predominantly required for bacterial persistence during 
the chronic stage of Mtb infection in mice (Pandey et al. 2008), indicating that the 
requirements for many of these central metabolic pathways are likely to change as 
infection proceeds.  Identifying the full complement of cellular functions necessary 
to utilize cholesterol has also revealed the scale of this nutritional adaptation during 
infection.  When we compared these data to previous genome-wide screens for 
mutants attenuated in mouse models of infection (Sassetti et al. 2003) we found 
that a full ten percent of genes specifically required for bacterial growth in vivo are 
also required for the utilization of cholesterol in vitro (Supplemental Table 3.1).  
These genes encode both dedicated sterol catabolic functions, as well as important 
steps in central metabolism.  Thus, while it is clear that Mtb must adapt to a variety 
of host-specific conditions to sustain a productive infection, our data suggest that a 
single nutritional change is responsible for a significant portion of this adaptation.  
)'
These cholesterol catabolic functions, in conjunction with the hundreds of other 
genes that we found to be essential for bacterial viability, both expand and refine 
the repertoire of targets for new TB therapies. 
 
Whole genome profiling techniques have proven to be useful tools for 
understanding complex pathways, such as those required for cholesterol utilization.  
Most of these approaches rely on determining the relative transcript or protein 
abundance.  However, these strategies make a major assumption – that critical 
genes are tightly regulated in response to metabolic changes.  While this may be 
true in many cases, it is often not.  In order to avoid this assumption, we have 
directly identified the genes required for growth, rather than those that are 
regulated. While every approach has its own inherent strengths and weaknesses, 
the phenotypic profiling strategy described here provides a powerful complement to 
other systems biology approaches used to understand bacterial physiology. 
 
)(
Chapter IV. Transcriptional and metabolic adaptations to intracellular 
growth on cholesterol. 
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Summary 
To understand the adaptation of Mycobacterium tuberculosis to the intracellular 
environment, we used comprehensive metabolite profiling to identify the 
metabolic pathways utilized during growth on cholesterol, a critical carbon source 
during infection. Metabolic alterations observed during cholesterol catabolism 
centered on propionyl-CoA and pyruvate pools, metabolites that are produced 
directly by the catabolism of cholesterol.   Growth on cholesterol required the 
transcriptional induction of the propionyl CoA assimilating methylcitrate cycle 
)*
(MCC) enzymes, a function mediated by the Rv1129c protein.  We show that 
both Rv1129c and the MCC enzymes were required for intracellular growth in 
macrophages, and the growth defect of MCC mutants was directly attributable to 
the degradation of host-derived cholesterol.  Together, these observations define 
a coordinated transcriptional and metabolic adaptation that is required for 
scavenging carbon during intracellular growth. 
 
Introduction 
The physiological state of intracellular pathogens is inextricably linked to the host 
cell in which they reside, and each pathogen is metabolically adapted to its 
specific niche.  Nutrition is a primary factor driving this adaption, as each 
pathogen is forced to subsist on locally-available host-derived compounds.  
Intraphagosomal pathogens, like Mycobacterium tuberculosis, must acquire 
these nutrients while surrounded by a host-derived lipid membrane (Appelberg 
2006).  Perhaps because of this sequestration, M. tuberculosis is thought to 
primarily catabolize these surrounding host lipids as carbon sources when 
growing in this compartment (Russell et al. 2010).   
 
The preferential use of lipid carbon sources by M. tuberculosis in vivo has been 
inferred from the transcriptional induction of genes encoding fatty acid 
degradation enzymes (Schnappinger et al. 2003), and from the requirement for 
specific pathways in central carbon metabolism, such as the glyoxylate cycle 
)+
(McKinney et al. 2000) and gluconeogenesis (Marrero et al. 2010), that are often 
essential for the utilization of nonglycolytic carbon sources by bacteria.  The 
identity of specific host lipids used by M. tuberculosis remained elusive until a 
dedicated cholesterol uptake and catabolic pathway was identified in the 
bacterium (Van der Geize et al. 2007).   The demonstration that these functions 
were necessary for the growth and survival of M. tuberculosis in chronically-
infected mice (Pandey and Sassetti 2008) verified that this single component of 
host membranes represents an essential nutrient during infection.   
 
However, it remained unclear whether cholesterol catabolism contributes 
significantly to the observed metabolic requirements for growth in the complex 
host environment.  Indeed, while cholesterol is catabolized to some extent 
throughout infection (Chan et al. 1995), cholesterol uptake mutants grow 
normally during the early preimmune phase of murine tuberculosis and in the 
relatively unstimulated macrophages that characterize this stage of infection 
(Pandey and Sassetti 2008).  These observations indicate that additional carbon 
sources must be available to the bacterium in vivo.  Fatty acids, sugars, and 
amino acids may all be available.  In addition, a variety of other environmental 
conditions encountered during infection, including altered O2, CO, NO, and H+ 
concentrations (Chan et al. 1995, Kumar et al. 2008, Rohde et al. 2007, Via et al. 
2008), could contribute to metabolic alterations.  To begin to understand how 
nutrition contributes to the metabolic adaptation to the host, we sought to 
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understand how the use of cholesterol, the only specifically defined carbon 
source in vivo, influenced the physiology of the bacterium during infection.  
 
To do this, we used comprehensive metabolite profiling to characterize the 
metabolic state of M. tuberculosis during growth on defined carbon sources 
including cholesterol.  Utilization of this compound profoundly altered the 
abundance of a variety of primary metabolites, most notably the intermediates of 
a propionly CoA catabolic pathway known as the methylcitrate cycle (MCC).  The 
activity of this pathway appeared to be rate-limiting for growth under these 
conditions, as transcriptional induction of the dedicated enzymatic steps by a 
divergently-encoded regulatory protein was essential.  While the three-carbon 
unit, propionyl CoA, can be derived from a variety of host components other than 
cholesterol, we demonstrate the requirement for this metabolic pathway in vivo is 
directly attributable to the utilization of this single host carbon source. 
 
Materials and Methods 
Growth and maintenance of bacterial strains  
All bacteria were maintained in complete Middlebrook 7H9 medium containing 
0.05% Tween 80 and albumin-dextrose-catalase supplement.  Kanamycin, 
Hygromycin, and Zeocin were used at 25 ug/ml, 50 ug/ml and 25 ug/ml, 
respectively.  For cholesterol experiments bacteria were grown in minimal media 
containing asparagine 0.5g/L, KH2PO4 1.0g/L, Na2HPO4 2.5g/L ferric ammonium 
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citrate 50mg/L, MgSO4 ·7H20 0.5g/L, CaCl2 0.5g/L, ZnSO4 0.1mg/L), 0.2% 
tyloxapol, 0.2% ethanol and either 0.1% glycerol or 0.01% cholesterol.  Where 
noted, Vitamin B12 (cyanocobalamin; Sigma) was added to a final concentration 
of 10 ug/ml. Growth was monitored by optical density at 600nm. 
Genetic manipulation of strains 
Marked Rv1129c was generated by “recombineering” essentially as described 
(van Kessel and Hatfull 2007), except the recombination functions were 
expressed from the pNIT::ET plasmid (GenBank no. GU459073).  Briefly, phage 
che9c recombination genes were induced in M. tuberculosis strain H37Rv by 
overnight incubation with 10"M isovaleronitrile. Bacteria were then 
electroporated with a linear substrate containing 500bp of homology to both the 
upstream and downstream regions of rv1129c flanking a hygromycin-resistance 
cassette.  The presence of both recombination junctions were verified by PCR 
and sequencing.  The absence of the rv1129c open reading frame was also 
confirmed by PCR.  Nucleotides 1253102-1254505 were deleted from the 
genome.  A complemented strain was generated by transforming the mutant with 
pJEB402 (Guinn et al. 2004) containing full length Rv1129c sequence 
(nucleodides 1253074-1254564 in the H37Rv sequence) cloned between HindIII 
and KpnI sites.  This plasmid integrates in single copy into the phage L5 attB site 
(Lee et al. 1991).  The construction of Icl1/2 mutants in M. tuberculosis strain 
Erdman was described in (Munoz-Elias and McKinney 2005).  prpDC mutants 
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were generated in H37Rv or an #mce4 mutant of H37Rv (Joshi et al. 2006) 
essentially as described in (Munoz-Elias et al. 2006). 
Metabolomic profiling 
Strains were grown in quadruplicate in 50mls of complete 7H9 medium until 
OD600 of 0.5 was reached.  Cultures were then washed in PBS twice and 
passed into minimal media with either 0.01% cholesterol or 0.1% glycerol for 48 
hours at 37°C.  Cells were harvested at 4000g for 5 minutes at 4°C and lysed by 
vortexing in 10 ml chloroform:methanol (2:1).  Samples were transferred to glass 
vials and dried under a stream of nitrogen, and subjected to LC/MS and GC/MS 
analysis as described (Evans et al. 2009).  
Macrophage infections  
Bone marrow-derived macrophages (BMMs) were isolated by culturing bone 
marrow cells from C57BL/6 mice in DMEM containing 10% FBS, 2 mM 
glutamine, 10% L929-conditioned medium, and 10 µg/ml ciprofloxacin for 5 days; 
$24 h before infection, differentiated BMMs were detached and seeded on a 24-
well tissue culture plate at 5 % 105 cells per well in the same medium lacking 
antibiotic. Macrophages were infected with different strains of M. tuberculosis at 
an moi of 1 for 4 h at 37°C. Extracellular bacteria were killed by incubating the 
cells with DMEM containing 100 µg/ml amikacin for 1 h followed by washing 
three times with warm PBS. Intracellular bacteria were quantified by lysing the 
cells with PBST at the indicated time points and plating dilutions on 7H10 agar. 
Q-PCR 
*%
Bacterial strains were grown in complete 7H9 medium until log phase, washed 
twice in PBS, and cultured in minimal medium with either 0.01% cholesterol or 
0.1% glycerol for 48 hours at 37°C.  Bacteria were centrifuged and resuspended 
in Trizol and lysed by bead beating.  RNA was isolated according to the 
manufacturers directions and DNAse treated (TURBO DNA-free Kit, Applied 
Biosystems). cDNA was generated using equal volumes of RNA from all samples 
(SMARTScribe Reverse Transcriptase, Clontech).  QPCR was conducted using 
iQ SYBR Green Supermix from BioRad and the following PCR paramters; 95°C 
for 10 minutes, 40 cycles of 95°C for 30 seconds, 62°C for 30 seconds, 72°C for 
30 seconds, read plate, 76°C for 2 seconds, read plate, 78°C for 2 seconds, read 
plate, 80°C for 2 seconds, read plate, 81°C for 2 seconds, read plate then 72°C 
for 1 minute, followed by a standard melting curve from 60°C-95°C. PCR primers 
for prpD forward were TGACTTTCACGACACGTTTCTGGC, prpD reverse were 
TGTGGATCTCATAGGCGGTTACCA, prpC forward were 
ATGGCTGGACATCTACCAGGTGTT and prpC reverse were 
TGTCGAATCCCATCAGGTAGTACG. Relative abundance of message was 
calculated by comparing all amounts for each gene relative to a standard curve 
from the H37Rv strain in cholesterol for the corresponding gene. In addition, all 
samples were normalized to sigA under the same conditions. 
 
Results 
Metabolomic profile of cholesterol catabolism  
*&
The dedicated pathway responsible for the degradation of cholesterol into 
primary metabolites remains to be completely elucidated, and the catabolism of 
this compound is predicted to produce an ill-defined mixture of propionyl CoA, 
acetyl CoA, and pyruvate (Van der Geize et al. 2007).  In order to characterize 
the central metabolic consequences of growth on this compound, M. tuberculosis 
was grown in minimal media with either glycerol or cholesterol as a primary 
carbon source.  Liquid- and gas-chromatography coupled mass spectrometry 
was then used to globally profile metabolite pools in each population.  Individual 
metabolites were identified by comparison to a library of retention times and 
masses of authentic standards, and the relative abundance of each metabolite 
was then determined with respect to carbon source.   
 
This analysis unambiguously identified 153 distinct metabolites, which were 
distributed throughout amino acid, carbohydrate, lipid, nucleotide, cofactor, and 
central carbon metabolism (Supplementary Table 4.1).  Overall, metabolite levels 
were comparable between these two cultures (Figure 4.1A) consistent with the 
similar doubling times observed in these two media (Pandey and Sassetti 2008).  
Further statistical analysis of these data identified 35 metabolites that 
accumulated to a significant degree in the cholesterol-grown cells.  (Table 4.1 
and Supplementary Table 4.1).  Among these compounds were all of the 
measurable intermediates of the MCC, a variant of the tricarboxylic acid cycle 
*'
used for the conversion of the three carbon unit propionyl-CoA into pyruvate 
(Pronk et al. 1994, Textor et al. 1997).   
 
A  
 
 
 
 
 
 
 
 
 
Figure 4.1 Metabolic profiling during growth on cholesterol.  Mtb was grown 
with either cholesterol or glycerol as the primary carbon sources and LC/MS and 
GC/MS were used to quantify the relative abundance of primary metabolites. (A) 
All 153 metabolites measured are plotted with abundance in glycerol and 
cholesterol on the y and x axis, respectively. Green and red metabolites 
accumulated during growth on glycerol and cholesterol, respectively and 
correspond to green and red labeled metabolites on figure 4.1B. 
 
Consistent with increased activity of the MCC, we also found an accumulation of 
amino acids derived from both the MCC intermediate oxaloacetate (OAA) and its 
product, pyruvate (Figure 4.1B).   Pyruvate may also be directly liberated from 
the cholesterol steroid nucleus during catabolism (Van der Geize et al. 2007) 
further increasing the abundance of this metabolite.  This analysis suggested that  
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Figure 4.1 Metabolic profiling during growth on cholesterol.  Mtb was grown 
with either cholesterol or glycerol as the primary carbon sources and LC/MS and 
GC/MS were used to quantify the relative abundance of primary metabolites. (B) 
Metabolites in red indicate those that significantly accumulated following growth 
on cholesterol relative to growth in glycerol.  Both the methylcitrate cycle, MCC 
and the glyoxylate cycle, GC are highlighted in blue.  
*)
Table 4.1 Metabolomic profile of cholesterol catabolism 
 
  Ratio  
BIOCHEMICAL NAME Cholesterol /  Glycerol P-VALUE 
tryptophan 2.07 0.0226 
2-aminoadipate 5.54 0.0022 
alanine 2.02 0.027 
beta-alanine 4.44 0.0098 
lysine 3.39 0.0424 
pipecolate 2.15 0.023 
S-adenosylhomocysteine (SAH) 1.85 0.0432 
threonine 2.86 0.0218 
isoleucine 2.33 0.0376 
methylsuccinate 16.28 < 0.001 
histidine 2.9 0.0195 
N-acetylornithine 2.19 0.0079 
serine 2.81 0.0259 
gamma-glutamylthreonine* 1.9 0.0205 
adenosine-5'-diphosphoglucose 3.45 0.0103 
mannose 4.02 0.0494 
mannose-1-phosphate 5.34 0.0125 
trehalose 6-phosphate 5.17 0.0224 
2-methylcitrate 22.81 < 0.001 
citrate 4.02 0.0054 
fumarate 2.95 0.0371 
malate 5.49 0.012 
succinate 4.67 0.0022 
7-alpha-hydroxycholesterol 8.9 0.006 
adenosine 5'-monophosphate 
(AMP) 1.73 0.0305 
thymidine 5'-monophosphate 3.38 0.0294 
pantothenate 5 0.0024 
nicotinate 3.66 0.0264 
nicotinate ribonucleoside* 2.91 0.0338 
nicotinic acid mononucleotide 
(NaMN) 2.2 0.0011 
 
“Ratio Cholesterol/Glycerol” = relative abundance of metabolite in cholesterol / 
relative abundance of metabolite in glycerol 
“P-value” = calculated using student t-test from quadruplicate samples. 
**
propionyl-CoA and pyruvate metabolism were central for the adaptation of M.  
 
tuberculosis to growth on cholesterol, and these metabolites were linked via the  
 
MCC.   
 
Propionyl CoA is liberated from the sidechain of cholesterol. 
In addition to fueling the MCC, propionyl CoA can also be used as a precursor for 
methyl branched chain lipid synthesis after conversion to methylmalonyl CoA 
(Jain et al. 2007).  We have previously shown that carbon derived from the 
branched sidechain of cholesterol was efficiently incorporated into mycobacterial 
lipids (Pandey and Sassetti 2008), making the sidechain terminus a likely source 
of propionyl CoA.  To more specifically characterize the metabolic fate of this 
moiety, we thoroughly analyzed the composition of the cellular lipids labeled after 
growth in  [26-14C]-cholesterol.  Upon profiling the total polar lipid extract, we 
found that a single species incorporated the vast majority of the 14C derived from 
[26-14C]-cholesterol, in contrast to [1,2-14C]-acetate which labeled a variety of 
other lipids.  Mass spectrometry was used to identify this species as sulfolipid-1 
(SL-1), one of the prominent methyl branched chain lipids of M. tuberculosis 
(Figure 4.2A).    
 
Since both the abundance and chain length of SL-1 is directly related to 
availability of the propionyl CoA precursor (Jain et al. 2007), we used these 
metrics to estimate the abundance of this precursor metabolite in cholesterol-
grown cells.  We found that both the molecular weight of SL-1 and its relative  
*+
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Cholesterol-derived propionate is incorporated into SL-1 and 
increases both its mass and abundance. (A) Total polar lipids were extracted 
from cholesterol-fed (lane 1) and acetate-fed (lane 2) bacteria and a cholesterol 
specific species was identified using MS as sulpholipid-1 (SL-1).  (B) MS was 
used to characterize the SL-1 from glycerol and cholesterol-fed bacteria. 
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abundance increased in cholesterol-grown cultures, compared to those grown in 
glycerol (Figure 4.2B).  This is consistent with the observed cholesterol-induced 
increase in length and abundance of a distinct methyl branched chain lipid, 
phthiocerol dimycocerosate (Yang et al. 2009 and data not shown), which is 
synthesized from the same precursor pool.  The preferential flux of cholesterol 
sidechain-derived carbon into SL-1 and the inferred increase in branched chain 
lipid precursors in cholesterol-grown cells both indicate that cholesterol is a rich 
source of propionyl CoA and that at least a portion of this metabolite is derived 
from the sidechain terminus.  
 
Functional MCC enzymes are required for growth in the presence of 
cholesterol.  
To determine the importance of propionyl CoA metabolism during growth on 
cholesterol, we tested the ability of MCC-deficient mutants to grow using this 
carbon source.  We found that the deletion of the prpC and prpD genes, 
encoding the two dedicated steps of this pathway, specifically impaired the 
bacterium’s ability to grow in media containing cholesterol as a primary carbon 
source (Figure 4.3A-D).  Similarly, deletion of the icl1 gene, which encodes a 
bifunctional methylisocitrate- and isocitrate-lyase that is necessary for both the 
MCC and glyoxylate cycles (Gould et al. 2006), caused a similar growth defect.  
Deletion of the partially-redundant icl2 gene, either alone or in combination with 
the icl1 mutation, had little effect. 
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Figure 4.3 The MCC genes are required for growth on cholesterol. prpDC 
mutants (A,C,E,G) and icl mutants (B,D,F,H) were grown in minimal media with 
the indicated carbon sources in the presence or absence of Vitamin B12. Optical 
density was measured at the indicated times.  
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In many bacteria, including mycobacteria, the inability to assimilate propionyl 
CoA inhibits growth even in the presence of other carbon sources (Munoz-Elias 
et al. 2006, Savvi et al. 2008).  This is likely due to the accumulation of 
intermediates that inhibit other essential pathways (Rocco and Escalante-
Semerena 2010).  Indeed, when we cultured #prpDC or #icl1 mutants in mixed 
carbon sources containing cholesterol, we observed growth defects that were 
comparable to the single carbon source media (Figure 4.3E-F).  To verify that 
this growth defect was due to propionyl CoA-related toxicity, we enabled an 
alternative assimilation system, the methylmalonyl pathway (MMP).  This 
pathway converts propionyl CoA into succinyl CoA via the B12-dependent 
methylmalonyl CoA mutase enzyme (Figure 4.1B), allowing MCC mutants to 
grow on propionyl CoA-generating substrates (Savvi et al. 2008).  Since M. 
tuberculosis is unable to synthesize B12 under these conditions, the MMP is only 
active upon B12 supplementation.  As anticipated, the addition of B12 to these 
mixed carbon source cultures reversed the growth defect imparted by MCC 
mutations (Figure 4.3G-H).  The modest residual defect of the #icl1 mutant in 
media containing only cholesterol may be attributable to the additional role 
played by this enzyme in another variant TCA cycle, the glyoxylate cycle.  We 
conclude that propionyl CoA metabolism is essential for growth in the presence 
of cholesterol. 
 
+%
Transcriptional induction of MCC genes by Rv1129c is required for 
propionyl CoA metabolism in vitro. 
The accumulation of MCC intermediates during the growth of M. tuberculosis on 
cholesterol suggested that the activity of the dedicated MCC enzymes were likely 
increased under these conditions.  Indeed, we found that the abundance of the 
mRNA encoding both prpC and prpD was increased by 5 fold in cholesterol-
grown cultures.  Encoded divergently from this transcript is the gene rv1129c 
(Figure 4.4A), which encodes a protein homologous to RamB, the regulator of icl 
gene transcription in actinobacteria (Micklinghoff et al. 2009, Gerstmeir et al. 
2004).  To determine if Rv1129c performed a similar function, we compared the 
level of prpDC mRNA in wild type bacteria with a strain in which the rv1129c 
gene had been deleted.  We found that transcript levels of both prpD and prpC 
were dramatically reduced in the absence of rv1129c regardless of carbon 
source, and that this phenotype could be complemented by expressing a wild 
type copy of the gene (Figure 4.4B).   
 
To determine the physiological relevance of this regulation we determined if the 
deletion of rv1129c altered growth on propionyl CoA generating substrates.  We 
found that the rv1129c mutant was unable to grow using either propionate or 
cholesterol as a primary carbon source (Figure 4.4C,E).  This phenotype was 
rescued either by genetic complementation or by adding B12 to circumvent the 
MCC requirement (Figure 4D,F), demonstrating that transcriptional induction of  
+&
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 The transcriptional activation of MCC genes by Rv1129c is 
required for growth in cholesterol. (A) Genomic organization of rv1129c and 
the MCC genes. (B) Relative abundance of prpD and prpC mRNA was measured 
48hrs following growth in vitro with either cholesterol or glycerol as the primary 
carbon sources. (C-F) Bacteria were grown in the defined carbon sources with or 
without vitamin B12 and monitored by optical density. 
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prpDC via Rv1129c is required for the assimilation of cholesterol-derived 
propionate. 
 
Cholesterol is a significant source of the propionyl CoA generated during 
intracellular growth. 
The dedicated MCC components PrpD, PrpC, as well as the multifunctional 
ICL/MCL enzymes are required for intracellular growth in macrophages (Munoz-
Elias et al. 2006, Munoz-Elias and McKinney 2005), indicating that propionyl CoA 
metabolism is critical in this niche.  However, it has remained unclear whether 
this requirement could be attributed directly to cholesterol catabolism.  To 
address this, we investigated the impact of cholesterol uptake on this phenotype. 
 
Initially, we sought to determine whether the observed intracellular growth defect 
of MCC mutants was due to propionyl CoA-related toxicity.  To do this we 
infected bone marrow-derived macrophages with M. tuberculosis and inhibited 
the MCC either by genetic deletion of prpDC or chemical inhibition of Icl1/2 with 
3-nitropropionate (3-NP) (Schloss and Cleland 1982).  Both MCC inhibition 
strategies resulted in a significant inhibition of intracellular growth.  Addition of 
B12 to enable the alternative methylmalonyl pathway caused a dose dependent 
reversal of this phenotype (Figure 4.5A).  Similarly, we found that the rv1129c 
regulatory mutant was unable to grow in BMDM unless supplemented with B12,  
 
+(
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Cholesterol is a significant intracellular source of propionate. (A) 
BMDM were infected with M. tuberculosis and icl was inhibited by the addition of 
3NP with or without vitamin B12 at the indicated concentrations.  Surviving 
bacteria were cultured at day 6 post-infection and resulting colony forming units 
(cfu) are plotted. (B) BMDM were infected with M. tuberculosis H37Rv or 
Rv1129c mutant and cultured in the presence or absence of vitamin B12 for 6 
days.  Surviving bacteria were plated and cfu were plotted. (C) BMDM were 
infected with M. tuberculosis H37Rv or Mce4 mutant and icl was inhibited with 
the indicated concentrations of 3NP.  Surviving bacteria are plated as % of 
growth. (D) BMDM were infected with the indicated mutants in the presence or 
absence of vitamin B12 and surviving bacteria were enumerated via cfu. Data is 
plotted as percent of growth. 
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suggesting that propionyl CoA toxicity was the basis for the growth defect 
observed for MCC-deficient strains (Figure 4.5B). 
 
We then investigated whether cholesterol contributed significantly to the bacterial 
propionyl CoA pool during intracellular growth.  To do this, we employed M. 
tuberculosis mutants lacking the Mce4 cholesterol uptake system, which are 
unable to import cholesterol but grow normally in resting BMDM (Pandey and 
Sassetti 2008, Mohn et al. 2008).  To estimate the propionyl CoA pool in wild 
type and mce4 mutants during intracellular growth, we compared the relative 
sensitivity of these strains to Icl1/2 inhibition with 3-NP.  The cholesterol uptake 
mutants were significantly more resistant to 3-NP, indicating that less ICL/MCL 
activity was necessary, and therefore that less propionyl CoA was generated in 
the absence of cholesterol catabolism (Figure 4.5C).  To verify this conclusion, 
we determined if the mce4 deletion was also able to suppress the growth defect 
of the #prpDC mutant.  Indeed, we observed that !mce4/!prpDC double mutants 
grew significantly more rapidly than #prpDC single mutants in BMDM, and the 
residual growth defect of the double mutants could be fully reversed by the 
addition of B12 (Figure 4.5D).  We conclude that MCC mutants are unable to 
grow intracellularly due to propionyl CoA toxicity and a significant fraction of this 
metabolite is produced via the catabolism of host cholesterol. 
 
Discussion 
+*
Many approaches have been used to determine how the intracellular 
environment influences the physiological state of a pathogen during infection.  
Most rely on identifying biochemical pathways that are expressed or essential 
during infection, and using this information to infer both the metabolic state of the 
cell and the environment that imposes this state.  However, the complexity of 
metabolic networks makes these inferences difficult, as a single enzyme can 
participate in multiple biochemical pathways, and the reliance on any pathway 
can be influenced by a number of different environmental factors.  This work 
employed a unique combination of direct metabolomic profiling and genetic 
epistasis analysis to functionally connect a distinct feature of the intracellular 
environment with its metabolic consequence in the pathogen.   
 
In order to understand the central metabolic adaptations required for the 
utilization of the host-derived carbon source, cholesterol, we globally surveyed 
the steady state levels of primary metabolites during growth on this compound.  
This approach is fundamentally different from more commonly used profiling of 
mRNA or proteins levels, which may not correlate with the metabolite levels 
(Jozefczuk et al. 2010).  We found that the differential utilization of a pathway 
could be predicted by the abundance of both its specific intermediates and its 
more stable biosynthetic products.  Labeling of proteinogenic amino acids has 
been used extensively to predict the flux through central carbon metabolism, and 
our data suggest that pool sizes of individual amino acids are also likely stable 
++
enough to serve this purpose.  Together, these data provided a holistic view of 
cellular metabolism and allowed us to identify pathways that were critical for 
cholesterol catabolism. 
 
The relatively dramatic accumulation of the PrpD substrate, methylcitrate, 
suggested that the constitutive levels this enzyme might be insufficient for the 
flux of propionyl-CoA derived from cholesterol.  Indeed, it appears that several 
propionate units are liberated from each cholesterol molecule.  In addition to the 
terminal sidechain carbons at least two other propionyl-CoA molecules may be 
produced (Van der Geize et al. 2007), suggesting that as much as one third of 
the carbon derived from cholesterol could enter the MCC.  While cholesterol 
appears to be a rich source of propionyl CoA, the incomplete suppression of the 
#prpDC mutant’s intracellular growth defect indicates that alternative carbon 
sources, such as odd chain fatty acids or branched chain amino acids, may also 
contribute to the propionyl-CoA pool during infection.  
 
The increased reliance on the MCC pathway during cholesterol catabolism was 
confirmed by demonstrating that transcriptional induction of the prpDC genes via 
the Rv1129c protein was required for growth.  This protein is highly homologous 
to the RamB regulator of both Mycobacteria and Corynebacteria, which controls 
the expression of the glyoxylate cycle enzymes necessary for growth on acetate.  
It has been proposed that the DNA binding function of the RamB protein of 
+,
Corynebacterium glutamicum is posttranslationally regulated (Micklinghoff et al. 
2009, Cramer et al. 2007), perhaps via binding of an intermediary metabolite. 
Thus, mycobacteria appear to use very similar regulatory proteins to control the 
pathways necessary for propionyl- and acetyl-CoA catabolism, and differential 
expression of these systems could be mediated via distinct allosteric regulation.   
 
Consistent with previous observations, we found that the growth of mutants 
lacking sufficient MCC activity was inhibited by propionate, even in the presence 
of an additional carbon source.  A similar phenomenon in Salmonella is due to 
the accumulation of a specific 2-methylcitrate isomer, which inhibits the 
gluconeogenic enzyme fructose 1,6 bisphosphatase (Rocco and Escalante-
Semerena 2010).  While a similar mechanism could underly propionate toxicity in 
mycobacteria, the type II FBP expressed by Mtb bears little if any resemblance to 
the Salmonella enzyme, suggesting that alternative mechanisms may be 
responsible. 
 
These metabolic insights provided the information necessary to test whether the 
MCC requirement during intracellular growth was due to host cholesterol 
utilization.  The ability of Mce4 mutation to alleviate the intracellular growth defect 
produced by either prpDC mutation or ICL/MCL inhibition implicate cholesterol as 
a major source of propionate in vivo even under conditions, such as growth in 
resting BMDM, in which cholesterol uptake is not absolutely required for growth.  
+-
This MCC mutant phenotype was reminiscent of strains lacking either the hsaC 
gene (Yam et al. 2009) or the “igr” locus (Chang et al. 2009, Chang et al. 2007), 
which encode functions dedicated to earlier steps in cholesterol degradation.  
Like MCC mutants, these strains are intoxicated in the presence of cholesterol, 
and are unable to grow in resting macrophages or acutely infected animals.  
Together, these observations strongly argue that M. tuberculosis obtains a 
significant amount of its carbon requirements from cholesterol throughout 
infection. 
 
In contrast to their absolute essentiality during intracellular growth in 
macrophages, the prpDC genes have been found to be dispensable for bacterial 
growth in the mouse model of TB (Munoz-Elias et al. 2006).  This was particularly 
surprising as cholesterol catabolism occurs throughout infection, and cell wall 
lipid alterations consistent with propionyl-CoA assimilation are evident in bacteria 
isolated from mouse tissue (Jain et al. 2007).  This apparent contradiction could 
be explained if the B12-dependent methylmalonyl pathway (MPP) were active 
under these conditions, either because the bacterium acquires B12 from the 
host, or some aspect of the host environment stimulates B12 production by the 
pathogen (Savvi et al. 2008).  Our observation that B12 supplementation 
reverses growth defect of prpDC mutants in macrophages, supports this 
hypothesis. 
 
,.
This work highlights propionyl-CoA assimilation as a critical feature of M. 
tuberculosis metabolism in vivo, and demonstrates that this requirement is a 
direct result of the nutritional environment in the mycobacterial phagosome.  
However, even within this relatively isolated compartment, the bacterium is likely 
to co-catabolize multiple carbon sources (de Carvalho et al. 2010), and inhibiting 
the bacterium’s ability to utilize individual nutrients is unlikely to represent a 
fruitful therapeutic strategy.  In contrast, interference with at least three distinct 
steps in cholesterol catabolism, via mutation of hsaC, igr, or MCC-encoding 
genes, results in metabolic toxicity that might be effectively exploited to treat TB.  
Thus, a fundamental understanding of mycobacterial physiology during infection 
is critical for identifying vulnerabilities that can be exploited for the rational design 
of more effective TB therapies. 
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Chapter V: The Mce lipid importers require a complex formation within the 
cell wall of Mtb 
 
 
Summary 
The dependence on Mce4 for cholesterol utilization demonstrates the need for 
effective transport of lipid substrates across the complex cell wall of Mtb.  The 
mechanisms by which any solutes transit this impermeable mycobacterial outer 
membrane remain ill defined.  By using the Mce systems as a model, we have 
begun to understand this process.  Each Mce operon encodes an inner 
membrane complex that resembles an ABC transporter and at least six proteins 
that are predicted to be secreted into the periplasmic space.  We hypothesized 
that these components may form a complex in the outer membrane that delivers 
substrate to the inner membrane components.  Here, we investigate this 
hypothesis by determining the subcellular localization of the secreted 
components encoded by the Mce1 operon, which is highly homologous to the 
Mce4 cholesterol importer.  By developing tools including peptide antibodies 
against Mce1 proteins and cell surface biotinylation conditions, we show that 
these Mce1 proteins are localized to the cell wall of Mtb and evidence is provided 
that suggests they form a complex with the inner membrane ABC-like 
components.  This complex depends on ATP hydrolysis generated by the 
associated ATPase, MceG.  Mechanisms for transport and the role of ATP 
hydrolysis are discussed.     
 
,&
Introduction 
It is clear that lipids play a vital role in TB infection, specifically during persistence 
(Pandey et al. 2008, McKinney et al. 2000).  Chapters III and IV describe the 
lengths to which Mtb has metabolically adapted to using one particular lipid, 
cholesterol, as an intracellular carbon source.  While Pandey and Sassetti have 
demonstrated that Mce4 is required for the bacterial transport of cholesterol, the 
mechanism for transport of lipids across the extremely complex Mtb cell wall 
remains elusive.  In fact, transport of solutes and nutrients in general in Mtb is not 
well understood.    
 
This lack of clarity stems from the complex and effective permeability barrier of 
the Mtb cell wall.  Recent investigations using cryo-electron tomography of intact 
mycobacterial cell walls demonstrate that despite the phylogenetic classification 
of Mtb as a Gram-positive organism, its cell wall has similarities to that of a 
Gram-negative organism (Hoffman et al. 2008, Zuber et al. 2008).  The Mtb cell 
envelope is comprised of a lipid bilayer plasma membrane and a complex cell 
wall.  An insoluble cell wall core is comprised of the covalently linked 
glycoconjugates peptidoglycan (PG) and arabinogalactan (AG) (Nierderweis et 
al. 2010).  Long chain (up to 90 carbons in length) mycolic acids (MA) are then 
esterified to AG and are a dominant component to the outer membrane, 
comprising between 30%-40% of the cell envelope mass (Brennan 2003, 
Nierderweis et al. 2010).  In addition to MAs, which comprise the majority of the 
,'
outer membrane (Hoffmann 08, Zuber 08), Mtb contains many additional free 
lipids intercollated into this outer structure.  These include cord 
factor/dimycolyltrehaolse (TDM), sulfolipids, phthiocerol dimycocerosate (PDIM), 
lipoarbinomannan (LAM), phoshatidylinositol mannosides (PIM), lipomannan 
(LM), etc. (Kaur et al. 2009).  Not only do the abundant mycobacterial lipids 
create an extremely hydrophobic and effective permeability barrier peripheral to 
the cell membrane, they are also important in virulence and host immune 
modulation (Karakousis et al. 2004). 
  
The unique complexity and hydrophobicity of the mycobacterial cell wall presents 
a challenge in understanding how nutrients and solutes are transported across it.  
Small hydrophilic substrates are able to diffuse through outer membrane proteins 
(OMPs) that form water-filled channels or porins spanning the outer membrane of 
gram-negative organisms.  OMPs have been difficult to identify in mycobacteria 
(Nierderweis et al. 2010).  The fast-growing saprophytic mycobacterial species 
M. smegmatis, has been shown to contain the OMP MspA, the most abundant 
protein in the organism, which is believed to serve as the major diffusion 
pathway.  Interestingly, expression of MspA in M. bovis BCG increased the 
growth rate of the organism, suggesting that the rate of hydrophilic nutrient 
uptake limits growth (Mailaender et al. 2004, Sharbati-Tehrani et al. 2004).  
There are no MspA homologues in Mtb and despite the identification of the 
suggested porins OmpATb and Rv1698, contradicting data precludes their 
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classification as true porins in Mtb (Raynaud et al. 2002, Siroy et al. 2008, 
Wolschendorf et al. 2011, Nierderweis et al. 2010). 
  
Diffusion rates through porins are extremely slow for hydrophobic solutes 
(Nikaido 2003).  Direct diffusion of fatty acids is slow and depends on the 
permeability of the lipid bilayer.  Differential scanning calorimetry has been used 
to determine the transition temperatures of mycobacterial cell wall lipids (Liu et 
al. 1995).  This study found that mycobacterial cell walls have abnormally high 
melting temperatures (60°C) indicative of very low fluidity at physiological 
temperatures and are thus, likely to be impermeable to even hydrophobic 
compounds like fatty acids. Thus, spontaneous diffusion of hydrophobic nutrients 
like cholesterol would occur too slowly, if at all to support growth.  Mycobacteria 
must, therefore, use additional transporters for such import.  In E. coli, the outer 
membrane transporter FadL mediates uptake of fatty acids across the OM in an 
energy-independent manner.  This process involves conformational changes 
resulting in import of long chain fatty acids (LCFA) to the periplasm.  Following 
the formation of uncharged LCFA, these lipids flip into and out of the IM (van den 
Berg 2005).  There are no known FadL homologues in Mtb and the process of 
lipid import is unclear.  
 
As noted in earlier chapters, Mce4 is required for the import of the lipid 
cholesterol in Mtb (Pandey and Sassetti 2008, Mohn et al. 2008).  There are four 
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Mce loci, mce1-4, in the genome of Mtb (Cole et al 1998).  Mce operons have 
homology to ABC transporters, of which there are exporters and importers.  ABC 
importers have only been identified in prokaryotes and are recognized by the 
presence of substrate binding proteins (SBP), nucleotide binding proteins that 
bind and hydrolyze ATP, and transmembrane permeases that span the inner 
membrane forming a pore for translocation.  Mce operons contain 8-12 genes 
encoding proteins with homology to both transmembrane permeases and SBPs.  
Each operon is identically organized within the chromosome and begins with 2 
yrbE genes each containing 6 predicted transmembrane domains with homology 
to permeases.  5 mce genes with homology to SBPs and 1 lpr gene encoding a 
predicted lipoprotein follow.  Although one report has indicated that Mce proteins 
may contain beta-barrel structures (Pajón et al. 2006), most prediction algorithms 
indicate the presence of 8 alpha-helices (Casali et al. 2007).  In addition, these 
proteins are predicted to have an N-terminal transmembrane helix followed by a 
cleavage site as predicted by SignalP.  Thus, Mce proteins are very likely 
secreted past the IM.  In fact, transmission electron microscopy has indicated 
that Mce4A is localized to the cell wall (Saini et al. 2008).  
  
While homology and other functional evidence indicate Mce loci encode ABC 
importers, Mce operons themselves are lacking a dedicated adenoside 
triphosphatse (ATPase).  Our lab first demonstrated that the unlinked gene,  
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Figure 5. Mce loci of Mtb. 
The 4 mce loci of Mtb are 
identically organized and 
encode predicted subunits of a 
lipid importers. 
 
 
 
 
 
rv0655 or mceG functionally interacted with both Mce1 and Mce4 (Joshi et al. 
2006).  MceG is part of a larger Mkl family of ATPases that is tightly conserved 
with Mce proteins throughout the Actinomycetales order and also cluster with the 
SBP-dependent importer clade of ABC transporters (Casali et al. 2007).  In 
addition, the presence of canonical Walker A and B motifs required for ATP 
binding and the ABC transporter family signature sequence, LSGGC, further 
support the role of MceG as a Mce-associated ATPase (Casali et al. 2007).  
ATPases physically interact with permease subunits in ABC transporters 
(Davidson and Chen 2004, Hollenstein et al. 2007).  YrbE proteins have been 
shown to contain a unique and conserved EExDA motif in the second to last 
cytoplasmic loop believed to interact with MceG (Casali et al. 2007).  We have 
demonstrated supporting evidence that the expression of YrbE1A-B is required 
for the stable expression of MceG in M. smegmatis (Joshi et al. 2006).  It is likely 
that Mce proteins form transporter complexes spanning the cell membrane and 
cell wall of Mtb. 
mce1 
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In this chapter, Mce1 is used as a model for lipid import.  Although the substrate 
for Mce1 is not known, the Mce1 locus is identically organized to the Mce4 locus, 
which we and others have shown to be required for cholesterol import (Pandey 
and Sassetti 2008, Mohn et al. 2008).  In addition, our lab has demonstrated that 
like Mce4, Mce1 functionally interacts with genes involved in lipid metabolism 
(Joshi et al. 2006). It is likely that like Mce4, Mce1 functions in lipid import.  Like 
Mce4, Mce1 mutants are attenuated in mice indicating their functional relevance 
in vivo (Sassetti et al. 2003, Joshi et al. 2006).  In addition, Mce1 is the most 
highly expressed mce loci during exponential growth in vitro (Kumar et al. 2003).  
Thus, in order to better understand lipid import in mycobacteria, the structure of 
this proposed complex was probed using a combination of a previously reported 
fractionation method for Mtb, purified peptide antibodies raised against Mce1 
proteins, and a novel cell surface biotinylation assay developed for Mtb.  Using 
these techniques, we further demonstrate the presence of an ordered Mce 
complex spanning the cell wall of Mtb and propose a novel role for MceG in the 
function of the transporter. 
  
Materials and Methods 
Growth and maintenance of bacterial strains  
,,
All bacteria were maintained in complete Middlebrook 7H9 medium containing 
0.05% Tween 80 and albumin-dextrose-catalase supplement.  Kanamycin and 
Hygromycin were used at 25 ug/ml and 50 ug/ml, respectively. 
Genetic manipulation of strains 
Mutations were made in the H37Rv background as previously described (Joshi et 
al. 2006).  Mce1, 2, 3, 4 quadruple mutant (Quad) was a generous gift from Jim 
Gomez and John McKinney.  
Mtb Cell Fractionation 
Mycobacterium tuberculosis H37Rv &lysA and &panCD auxotroph (mc26020) 
was used for all fractionation experiments and was created in the laboratory of 
Dr. Bill Jacobs (Sambandamurthy et al. 2005).  Bacteria were grown to an optical 
density at 600nm of 1.0 in 50mls of complete 7H9 media with lysine (1mg/ml) 
and pantothenate (24ug/ml) then washed in PBS twice and passed into 200mls 
of Sauton’s minimal media (KH2PO4 0.5g/L, MgSO4  7H20 0.5g/L, citric acid 
2.0g/L, ferric ammonium citrate 0.05g/L, glycerol 60ml/L, asparagine 4g.0g/L) 
with 0.05% Tween 80 with leucine and pantothenate supplements as above.  
Culture grew aerobically in a roller bottle until it reached an optical density at 
600nm of 0.75-1.0 when cells were harvested at 4400g for 10 minutes at room 
temperature.  Bacterial pellets were kept at -80°C until fractionated as previously 
described (Rezwan et al. 2007).  Briefly, cells were washed in 0.16M NaCl, 
incubated with lysozyme (2.4mg/ml) for 2hrs at 37°C and sonicated in an ice 
water bath.  Unbroken cells were removed via centrifugation and lysates were 
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centrifuged at 27,000g for 40 minutes at 4°C to isolate cell walls.  The resulting 
pellet was separated by centrifugation at 100,000g for 1hr at 4°C into the 
bacterial membrane (pellet) and cytosol (supernatant).  All fractions were 
resuspended in the same volume of PBS and protease inhibitors (Protease 
Inhibitor Cocktail tablets, Roche) and equal volumes were used in all analyses. 
Fractions were oliquoted and frozen at -80°C until used.  Cell wall fraction was 
boiled in 0.1% SDS for 30 minutes and cytosol and membrane fractions were 
filtered using 0.2uM filter before fractions were used in biosafety level 2 
conditions. 
Cell Surface Biotinylation 
Mtb H37Rv was used for all biotinylation experiments and was grown in complete 
7H9 media with 0.05% Tween 80 and albumin-dextrose-catalase supplement 
until an optical density at 600nm of 1.0.  Culture was then washed in PBS twice 
and passed to an optical density at 600nm of 0.3 in complete 7H9 with or without 
0.05% Tween 80.  Following growth for 48hrs, cultures were washed 3x in PBS, 
concentrated 50x in PBS and incubated with 1mM NHS-Biotin (EZ-Link NHS-
Biotin, Thermo Fisher Scientific) for 10 minutes at room temperature.  Samples 
were washed once with 50mM Tris, pH 8.0 and then twice with PBS and 0.05% 
Tween 80 and resuspended in PBS and protease inhibitors.  Samples were lysed 
via mechanical rupture using glass beads for 30 seconds each at 6.5 speed 
using a FastPrep FP120 machine with 1-2 minute incubations on ice in between.  
Samples were boiled in 1.0% SDS for 30 minutes before removal from the 
-.
biosafety level 3 facility and then spun at max speed for 5 minutes at 4°C 
(lysate).  The supernatant was diluted to 0.06% SDS in cold PBS and incubated 
for 1hr at 4°C with either streptavidin (High Capacity SA Agarose Resin, Thermo 
Fisher Scientific) or glutathione S-transferase (GST) (GST-Bind Resin, Nalgene) 
coated beads and spun at max speed for 30 seconds at 4°C.  The resulting 
supernatant was TCA precipitated by incubation with an equal volume of ice-cold 
20% TCA at 4°C overnight.  Samples were then washed once with ice-cold 
acetone and air dried for an hour at room temperature and resuspended in 
sample buffer and boiled 30 minutes (unbound fraction).  Beads were washed 
once with cold PBS and protease inhibitors at 4°C and boiled in sample buffer 
(bound fraction).  Lysate, bound and unbound fractions were then probed via 
western blot.   
Western Blots 
All protein samples were boiled in sample buffer (50mM Tris-HCl, pH 6.8, 1% 
SDS, 0.1% bromophenol blue, 10% glycerol, 1% !-mercaptoethanol) for 30 
minutes.  Samples were then run on 10% denaturing polyacrylamides, 
transferred to polyvinylidene fluoride (PVDF) and membranes were blocked 
overnight in blocking buffer (5% milk, 0.1% Tween 20 and 1.0% goat serum in 
PBS).  Membranes were probed via western blot by incubation with 1ug primary, 
purified peptide antibodies for 1hr in blocking buffer at room temperature with 
gentle rocking.  Membranes were washed 3x for 15 minutes in PBS and 
incubated with anti-rabbit IgG conjugated with horseradish peroxidase (HRP) at 
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1:2500 dilution in blocking buffer for 1hr at room temperature with gentle rocking.  
Membranes were then washed 4x for 15 minutes at room temperature with 
gentle rocking and developed using chemiluminescent substrate for detection of 
HRP according to manufacturer’s instructions (ECL Western Blotting Substrate, 
Pierce). 
Peptide Antibody Purification 
Short (19 amino acids) peptides were generated by Open Biosystems (Thermo 
Fisher Scientific) and inoculated into rabbits.  Crude antibody serum was then 
purified using immunoaffinity purification following the immobilization of peptides 
to solid support (HiTrap NHS-activated HP, GE Healthcare) according to 
manufacturers instructions.  Briefly, 1mg of peptide was dissolved in coupling 
buffer (0.2M NaHCO3, 0.5M NaCl, pH 8) and incubated with matrix for 30 
minutes at room temperature.  Peptide bound matrix was then washed and 
deactivated with alternating washes with Buffer A (0.5M ethanolamine, 0.5M 
NaCl, pH 8) and Buffer B (0.1M acetate, 0.5M NaCl, pH 4). Bound matrix was 
stored in storage solution (0.05M Na2HPO4, 0.1% NaN3, pH 7) until serum 
immunoaffinity purifcation.  Bound matrix was prepared for serum purification by 
washing with 10 bed volumes each of 10mM Tris (ph 7.5), 100mM acetate (pH 
2.5), 10mM Tris (pH 8.8).  10 bed volumes of 100mM triethylamine (pH 11.5) 
made fresh was then passed through the matrix followed by one wash with 
10mM Tris (pH 7.5).  Polyclonal serum was passed through a 0.2uM filter and 
diluted 1:10 in 10mM Tris (pH 7.5) and then passed slowly over the matrix 3 
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times.  Matrix was then washed with 20 bed volumes each of 10mM Tris (pH 7.5) 
and 500mM NaCl, 10mM Tris (pH 7.5).  An acid elution was conducted by 
passing 10 bed volumes of 100mM acetate (pH 2.5) and eluate was collected 
and neutralized with 1M Tris (pH 8).  Matrix was then washed once with 10mM 
Tris (pH 8.8) and eluate was collected.  A base elution was conducted by passing 
10 bed volumes of 100mM triethylamine (pH 11.5) made fresh and eluate was 
collected and neutralized with 1M Tris (pH 8).  Collected eluates were 
concentrated via centrifugation over a 30kD Amicon centriplus centrifugal device 
(Millipore) and quantified at 280nm.   
 
Results 
Mce proteins localize to the cell wall 
The presence of predicted signal cleavage sites at the N-terminus of Mce 
proteins strongly suggest their localization peripheral to the IM.  In order to 
demonstrate this, Mtb was fractionated into cytosol and cell wall fractions using a 
previously validated protocol (Rezwan et al. 2007).  Using specific peptide 
antibodies developed against Mce1 proteins, cell fractions were probed for the 
presence of Mce1 proteins.  These experiments demonstrate that all Mce1 
proteins, including the lipoprotein LprK, localize preferentially to the cell wall 
fraction of Mtb confirming their translocation past the IM (Figure 5.1). Notably, 
Mce1 proteins were not detected in bacterial supernatants, suggesting that in 
vitro, Mce1 proteins are not secreted (data not shown).  
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Figure 5.1 Mce1 proteins localize to the cell wall fraction of Mtb.  Mtb H37Rv 
was grown to exponential phase, harvested and fractionated using differential 
centrifugation as described in materials and methods. Equal volumes of each 
fraction, C (cytosol) and W (cell wall) were probed via western blot using purified 
peptide antibodies against appropriate Mce proteins. 
 
Mce1 proteins are differentially localized within the cell wall. 
It became apparent through the above experiments that the detection of many of 
the Mce1 proteins was dependent on bacterial lysis via a mechanical disruption 
technique involving glass beads, a common method for mycobacterial cell 
disruption.  This suggested they were buried in the cell wall and prompted 
investigations into the localization of Mce1 proteins within the cell wall.  Despite 
unsuccessful attempts at localizing Mce1 proteins using transmission electron 
microscopy, we were able to demonstrate subcellular localization of Mce1 
proteins in the cell wall by developing conditions that allowed for the specific 
biotinylation of cell wall proteins.  By combining the labeling of surface exposed 
primary amines using an NHS-activated biotin molecule with streptavidin 
immunoprecipitation, the subcellular localization of cell wall proteins was 
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determined.  Figure 5.2 shows that in the absence of the detergent Tween 80, 
the predicted IM bound serine-threonine kinase PknB (Young et al. 2003), is not 
accessible to the membrane-impermeable biotin molecule, but is accessible in 
the presence of the detergent. In contrast, the outer membrane protein OmpATb 
displays consistent biotin accessibility.  These results demonstrate that cell 
surface biotinylation of Mtb in the absence and presence of Tween 80 can detect 
both exposed outer membrane proteins and proteins exposed to the periplasm, 
respectively. 
  
 
Figure 5.2 Mce1 proteins are differentially accessible to membrane 
impermeable biotin.  Mtb H37Rv was grown as described in the presence or 
absence of 0.05% Tween 80 and biotinylated according to materials and 
methods. Following mechanical lysis of biotinylated cells, immunoprecipitation of 
biotinylated molecules using either streptavidin (SA) or GST coated agarose 
beads was performed. Equal volumes of each (L) lysate, (U) unbound, (B) bound 
fractions were probed via western blot using purified peptide antibodies. 
 
By probing for the presence of Mce1 proteins in the above conditions, differential 
biotin accessibility was demonstrated for Mce1 proteins.  Mce1A, 1B, 1C, and 1D 
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are accessible to biotinylation only in the presence of Tween 80, while LprK and 
Mce1F are inaccessible to biotin regardless of the presence or absence of the 
detergent.  These results indicate that while all Mce1 proteins localize to the cell 
wall (Figure 5.1) a subset of these including Mce1A, 1B, 1C and 1D are 
peripheral to the more buried LprK and Mce1F proteins.  
 
MceG function is required for Mce1 protein stabilization 
While circumstantial evidence exists suggesting Mce proteins assemble into lipid 
importer complexes, direct experimental evidence was lacking.  The stability of 
bacterial transporters has been demonstrated to be dependent on the presence 
of proteins within that complex (Berger and Christie 1993, Fernandez et al. 
1996).  Consistent with that observation, Joshi and colleagues have shown that 
the stability of MceG is dependent on expression of Mce1 proteins in M. 
smegmatis.  Here, Figure 5.3 demonstrates that in the absence of MceG or an 
MceG point mutant (K66N) rendering the enzyme unable to bind ATP (Henriksen 
et al. 2005), Mce1 proteins are not present.  Transcription of Mce1 proteins is not 
altered in these MceG mutants (personal communication, Sassetti, CM).  
Therefore, the stability of Mce1 proteins is dependent on a functional copy of 
MceG. 
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Figure 5.3 MceG-dependent ATP hydrolysis is required for Mce1 complex 
stabilization.  Bacteria was grown to exponential phase and mechanically lysed. 
Equal amounts of lysate, relative to optical density, were probed via western blot 
using purified peptide antibodies. (Rv) H37Rv, (1) Mce1 operon mutant, (Q) 
Mce1-4 quadruple mutant, (G) MceG mutant. (Pt) MceG point mutant (K66N), 
(GC) MceG complement. 
 
Discussion 
In this chapter, Mce1 proteins were localized to the cell wall fraction of Mtb and 
data is provided to support the presence of an ordered transporter complex 
spanning the cell wall.  The fact that a subset of Mce1 proteins are differentially 
biotinylated in the presence or absence of Tween 80, argues that some Mce 
proteins, including the lipoprotein LprK and Mce1F, are more buried in the cell 
wall than others.  Alternatively, we cannot rule out the possibility that the 
detergent itself can modify the overall structure of the transporter.  This caveat is 
difficult to control for in the highly complex cell wall of Mtb, where structural 
organization of any cell wall apparatus is not clear.  In addition, since the 
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irreversible biotinylation reaction requires a free amine group, it is possible that 
Mce1F and Lprk are folded or interacting with other proteins or themselves in a 
manner that does not provide free amine groups. Although with over 100 lysine 
residues between the two proteins, this is highly unlikely.   
 
As noted above, bacterial transporter complexes have been shown to display 
mutual stabilization (Berger and Christie 1993, Fernandez et al. 1996) and here, 
evidence is provided to suggest the same occurs with Mce transporters.  
Although there is similarity regarding complex stabilization, data here is novel in 
that the energy generating subunit is functionally required for subunit stability.  
ATPases are required for generating energy for translocation and in some 
secretions systems the assembly of the secretion machinery itself (Sagulenko et 
al. 2001).  In this way, MceG could also be providing the energy for translocation 
and assembly of the Mce1 complex.  This would be surprising for two reasons.  
First, as noted above, all Mce proteins are predicted to contain a signal peptide 
cleavage site indicating their likely secretion by the classical Sec secretion 
apparatus.  Second, Mce1 is most likely, as in the case of Mce4, a lipid importer 
not an exporter.  Thus, this would be the first example of an ATPase providing 
both the energy for secretion of complex subunits and also for the import of a 
substrate.  Alternatively, ATP hydrolysis provided by MceG may only be 
necessary for complex assembly and lipid import across the IM may happen 
either in an energy-independent fashion, like the ‘flip-flop’ mechanism of LCFAs 
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following import by FadL (van den Berg 2005) or another IM transporter my be 
required for this process.  As no other apparent transporter complex was found to 
be required for cholesterol utilization in chapter III, the latter is unlikely.         
 
While it is clear that the stability of Mce1 proteins require MceG, it is unclear what 
might be degrading Mce1 proteins in the absence of the ATPase. Genomic 
analysis suggests that Mtb contains over 40 predicted proteases (Ribeiro-
Guimarães and Pessolani 2007).  These include ClpX-like proteases as well as 
periplasmic DegP-like serine proteases, HtrA1-3.  Efforts using a DegP-specific 
irreversible protease inhibitor diisopropyl fluorophosphate (DFP) (Krojer et al. 
2010) showed that in the presence of DFP Mce1 protein stability was not 
restored and may suggest that Mce1 proteins are degraded in the cytosol (data 
not shown).  While the transcription of Mce1 proteins is unaltered in the MceG 
point mutant (personal communication, Sassetti, CM), it also remains possible 
that Mce1 proteins are not translated or partially translated in the absence of a 
functional ATPase.  It is possible that similar to SecA-dependent co-translation of 
translocated proteins, MceG may be intimately involved in the 
translation/translocation of Mce1 proteins and in the absence of a functional 
MceG, translation is inhibited (Papanikou et al. 2007). 
 
Mce proteins were originally identified for their ability to promote uptake of non-
invasive E.coli in epithelial cells and were therefore named mycobacterial cell 
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entry proteins. (Arruda et al. 1993).  Although many have reproduced similar 
results using latex beads coated with recombinant Mce proteins (Chitale et al. 
2001, Lu et al. 2006, El-Shazly et al. 2007), the mechanism for this observation 
and its relevance in vivo is not understood.  It is possible that lipid-binding outer 
membrane Mce proteins may interact with mammalian membranes in a manner 
that could promote uptake.   
  
In vivo phenotypes of Mce mutants have generated mixed results.  TraSH 
experiments have identified Mce1 mutants to be attenuated as early as 1 week 
following infection, whereas Mce4 mutants display greatest attenuation following 
the adaptive immune response between weeks 3 and 4 following infection 
(Sassetti et al. 2003).  We have verified these phenotypes using transposon 
mutants in a competitive infection model (Joshi et al. 2006).  In single strain mice 
infections, Mce1 mutants have been reported to demonstrate a hypervirulence 
phenotype by week 4 (Shimono et al. 2003).  It is not clear why these results are 
inconsistent, although the immune status of the host might play a role in 
determining the outcome of Mce1 mutants.   
 
Although we and others have demonstrated that Mce4 functions in cholesterol 
import, the substrate for Mce1 remains elusive (Pandey and Sassetti 2008, Mohn 
et al. 2008).  Immediately upstream of and encoded in the same direction as the 
YrbE1 genes, lies FadD5.  FadD5 is predicted to encode a fatty acyl-coenzyme A 
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synthetase, catalyzing the first step in fatty acid degradation (Cole et al. 1998).  
And although this mutant has been shown to display a reduced in vitro growth 
rate in media containing mycolic acid as the sole carbon source, this phenoypte 
was independent of the Mce1 operon (Dunphy et al. 2010).  Although Mce1 does 
not play a role in mycolic acid transport, it is likely that it transports another lipid 
utilized by Mtb.  Evidence suggests that lung surfactant contains LCFAs including 
dipalmitoyl phosphatidylcholine and can be phagocytosed by alveolar 
macrophages (Gräbner and Meerbach 1991).  It has been demonstrated that Mtb 
can utilize such a lipid in a glyoxylate cycle-dependent fashion and as mentioned 
above, it is likely this would require a transporter for efficient growth on such a 
compound.  Mtb is bound by the phagosomal membrane; a lipid bilayer 
containing various lipid carbon sources.  Utilizing these lipids would require both 
their transport and hydrolysis by lipases.  Mtb encodes 20 putative lipases, 
including 4 secreted phospholipases C enzymes required for virulence (Raynaud 
et al. 2002, Cole et al. 1998).   Lipase freed membrane lipids could serve as 
potential carbon sources and substrates for Mce1.  In addition, Mtb can 
catabolizes TAGs, which are freed in macrophages during phagocytosis (Alvarez 
and Steinbüchel 2002, Mason et al. 1972).  Whatever the substrate of the Mce1 
transporter, it is required during the early stages of TB infection (Sassetti et al. 
2003) and will thus, shed light on the variety of lipids that are likely metabolized 
by Mtb during this important stage of infection. 
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Chapter VI: Discussion 
 
Cholesterol is a vital molecule for human biology and thus, it is no surprise that 
human pathogens exploit it.  The role of cholesterol during bacterial and viral 
infections has been extensively studied.  Cholesterol plays important roles in viral 
budding and replication, bacterial invasion and replication, and evasion of the 
host immune response (Ye 2007, Garner et al. 2002, Lamberti et al. 2008, 
Wunder et al. 2006, Golusko and Nowicki 2005, Hayward et al. 2005, Mackenzie 
et al. 2007).  Mycobacteria use cholesterol during various aspects of its life cycle 
including invasion and inhibition of lysosome fusion (Gatfield and Pieters 2000, 
de Chastellier and Thilo 2006).  Recently, the demonstration that Mtb utilizes 
cholesterol as a carbon source represented a novel use of this host-derived 
molecule during the course of TB infection (Pandey and Sassetti 2008, Mohn et 
al. 2008).  Here, I have demonstrated how Mtb has adapted to utilizing this 
molecule in a rather unique capacity.  It is clear that utilizing cholesterol as a 
carbon source requires both significant metabolic adaptations and a unique 
dedicated uptake system.  The significant adaptations argue that cholesterol is 
an advantageous intracellular carbon source, but they provide little evidence as 
to why.  And although the answer remains unclear, evidence supporting several 
hypotheses now exists.  
 
The Bioavailability of Cholesterol 
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Mtb requires cholesterol during the chronic phase of infection, but catabolizes it 
throughout the course of infection (Pandey and Sassetti 2008, Chang et al. 
2009).  Cholesterol therefore, must be available throughout infection.  It is 
possible that Mtb has evolved to rely on cholesterol during discrete times 
throughout infection based on the bioavailablity of various carbon sources, 
including cholesterol.  The plasma membrane is a rich source of cholesterol early 
during invasion by mycobacteria (Gatfield and Pieters 2000).  Because bacterial 
replication occurs in a phagosome-like vesicle believed to be part of the recycling 
network, the intracellular membranes including the phagosome membrane itself 
is likely a source of cholesterol during early replication (Clemens and Horwitz 
1996).  Filipin, a fluorophore with specific cholesterol binding activity, has been 
used to localize cholesterol in infected macrophages and these experiments 
have demonstrated that Mtb co-localizes with cholesterol in a perinuclear area 
independent of the activation state of the infected macrophage (Pandey and 
Sassetti 2008).  Thus, evidence suggests that Mtb has access to cholesterol-rich 
intracellular membranes pre- and post-IFN' activation.  It is likely though, that 
following IFN' activation when the phagosome is no longer part of the recycling 
network, carbon sources may become limiting.  This carbon limitation may be 
driving the requirement of cholesterol during persistence.  
 
As disease progresses, the presence of lipid bodies (LB) containing TAG, 
phospholipids and cholesterol esters among other lipids, become more abundant 
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within the infected macrophage (Russell et al. 2009).  Both mouse and guinea 
pig models have shown that early LBs are present as soon as 2 weeks post 
infection and continue to develop and mature into foam cells following adaptive 
immunity (Cáceres et al. 2009).  In addition, macrophages infected with Mtb 
develop into foam cells in vitro and this is dependent on stimulation of Toll-like 
receptor 2  (D’Avila et al. 2006).  In humans, foamy macrophages can comprise 
the majority of infected cells in advanced caseating and cavitating granulomas 
(Peyron et al. 2008).  Foamy macrophages consist of intracellular stores of 
cholesterol and cholesterol esters as a result of the dysregulation of cellular lipid 
metabolism.  These cells, which are co-infected with Mtb represent a huge 
reservoir of cholesterol and thus a plentiful carbon source during later stages of 
infection.  Electron microscopy has demonstrated that infected foamy 
macrophages contain Mtb-infected vesicles that are tightly aligned and in some 
cases within the same compartment as cholesterol-filled lipid bodies (Peyron et 
al. 2008, Russell et al. 2009).   The cavitation of TB granulomas results in 
bacteria replicating extracellularly, where cholesterol exists in circulating 
lipoprotein particles, as well as insoluble cholesterol crystals (Hunter et al. 2007).  
The bioavailability of cholesterol throughout infection suggests that cholesterol 
and in particular cholesterol esters become increasingly available and accessible 
to both intracellular and extracellular bacteria.   
 
Cholesterol and Redox Balance 
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In addition to using cholesterol because it is available, Mtb may also catabolize 
this molecule because it serves additional purposes during infection.  The 
catabolism of cholesterol causes an increase in propionyl-CoA.  In addition to the 
MCC, the methylmalonyl pathway (MMP) metabolizes propionyl-CoA into 
methylmalonyl CoA (MMCoA), an important precursor to virulence lipids such as 
PDIM and SL-1 (Savvi et al. 2008).  We and others have shown that these 
virulence lipids increase in mass and abundance during growth on cholesterol 
(Pandey and Sassetti 2008, Yang et al. 2009, Jain et al. 2007).  It has been 
proposed that the consumption of NADH by the MMP may be an important redox 
regulator during growth on lipids, as both !-oxidation and the MCC generate this 
reducing agent.  Thus, in addition to increasing the pathogenecity of the 
organism, lipid anabolism is thought to serve as a reductant sink for NADH being 
generated via cholesterol catabolism, which otherwise may cause an imbalance 
to redox homeostasis (Singh et al. 2009).   
 
Cholesterol and Secondary Metabolites 
In addition to providing energy and biosynthetic precursors for lipid anabolism, 
cholesterol may also serve as a precursor for secondary metabolites such as 
steroid hormones.  Following side-chain cleavage, cholesterol is enzymatically 
modified into pregnenolone, which is the precursor for glucocorticosteroids.  
Glucocorticosteroids are well documented as effective immunosuppressants 
(Nikhil et al. 2004) and other pathogens are believed to modulate cholesterol 
%.)
levels in the host in order to take advantage of this phenomenon (Reading et al. 
2003, Mackenzie et al. 2007).  In addition to glucocorticoids, androgens can be 
synthesized from cholesterol and have demonstrated various effects on the 
immune system (Gilliver 2010).  Nesbitt and colleagues have demonstrated that 
the precursors to androgens, androsten-4-en-3, 17-dione (AD) and adrosta-1,4-
dien-3,17-dione (ADD) accumulate in the supernatants of Mtb grown in the 
presence of cholesterol in vitro (Nesbitt et al. 2010).   
 
An important enzymatic step in the conversion of cholesterol into steroid 
hormones is the oxidation of the 3!-hydroxyl group.  Here, of two potential 
enzymes predicted to mediate this step, rv1106c, encoding a 3!-hydroxysteroid 
dehydrogenase is the only gene that when mutated causes a growth defect in 
cholesterol.  Rv1106c is predicted to be intracellularly expressed (Kreit and 
Sampson 2009).  As most intracellular 3!-hydroxysteroid dehydrogenases are 
involved in steroid hormone biosynthesis, it is possible that Rv1106c may be 
involved in both the catabolism of cholesterol and the synthesis of steroid 
hormone precursors (Kreit and Sampson 2009).   
 
There are two reasons that make the conversion of cholesterol to steroid 
hormones an unlikely alternative for cholesterol utilization in Mtb.  First, the 
accumulation of AD and ADD in cell culture supernatants is likely an in vitro 
artifact with little relevance in vivo.  In fact, metabolite leakage in vitro is a well-
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documented phenomenon (Shin et al. 2010).  Second, the release of C14 C-4 
into CO2, indicates that Mtb has the ability to completely degrade the steroid 
nucleus.  The production of both glucocorticoids (C21 molecules) and androgens 
(C19 molecules) require an in tact steroid nucleus.   
 
Cholesterol and Pyruvate 
Several lines of evidence from this work support the importance of metabolizing 
pyruvate during growth on cholesterol.  First, pyruvate is a direct byproduct of 
sterol ring degradation (Yang et al. 2009).  In addition, growth on cholesterol is 
dependent on a functional MCC, which converts toxic propionate into additional 
pyruvate.  Second the accumulation of alanine, tryptophan and serine indicate 
increased flux through biosynthetic pathways stemming from pyruvate.  Third, the 
requirement of ppdK for growth on cholesterol indicates that the metabolism of 
pyruvate to PEP, and more generally gluconeogenesis, is an important metabolic 
adapation to growth on cholesterol.  In addition, mutations to lactate 
dehydrogenase (lldL1, rv0694) result in a significant growth defect in cholesterol.  
Lactate dehydrogenase mediates the interconversion of lactate and pyruvate, 
consuming NADH during the conversion of pyruvate to lactate.  One possible 
explanation for the requirement of lactate dehydrogenase is that the production 
of pyruvate during cholesterol catabolism requires many outlets for pyruvate 
metabolism, including the conversion to lactate.  LldL mediated conversion of 
pyruvate to lactate would also consume excess NADH produced during 
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cholesterol metabolism helping to restore redox balance.  Alternatively, the 
conversion of lactate to pyruvate may be necessary to feed gluconeogenesis 
needed to produce biosynthetic precursors essential for cell viability, including 
tryptophan and serine, both of which accumulated following growth on 
cholesterol.  Further analysis is needed to differentiate between both possibilities, 
but the requirement of lactate dehydrogenase further supports the importance of 
pyruvate metabolism during growth on cholesterol. 
 
Cholesterol and TB Susceptibility 
The importance of cholesterol during the course of TB infection leads one to 
consider if patients with altered cholesterol levels are more susceptible to 
disease.  While studies have suggested that TB patients are hypocholesterolemic 
(Pérez-Guzmán and Vargas 2006, Deniz et al. 2007), it is currently unknown if 
pre-existing hypercholesterolemia predisposes patients to TB.  In an attempt to 
answer this question, mice with defects in lipoprotein processing were fed high-
cholesterol diets and then infected with Mtb via the aerosol route.  Interestingly, 
these mice were more susceptible to Mtb and this was dependent on elevated 
serum total cholesterol levels (Martens et al. 2008).  While the same has yet to 
be observed in human patients, these results indicate that cholesterol plays a 
pivotal role in TB susceptibility. 
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In summary, the work presented here highlights the complexity of Mtb physiology 
and the lengths at which this organism has gone to adapt to its unique niche.  As 
humans are the sole reservoir for this highly infectious pathogen, it is evident that 
Mtb has evolved to be metabolically flexible enough to utilize its available carbon 
sources.  By better understanding these adaptations, we may continue to 
elucidate novel pathways to target with unique antitubercular drugs.  For 
example, the absence of the isocitrate lyase in the mammalian host represents a 
novel drug target that is vital for intracellular growth on cholesterol.  In addition, 
the design of drugs aimed at causing the buildup of toxic metabolic intermediates 
such as propionate, may represent a novel avenue for drug therapy.  It is clear 
that a better understanding of basic Mtb physiology will continue to elucidate the 
mechanisms used by such an effective pathogen. 
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Appendix 
 
Supplementary Table 2.1 Sequence reads detected per TA insertion site. 
Supplementary Table 2.2 Analysis of essentiality in vitro. 
Supplementary Table 3.1 Differential growth in glycerol and cholesterol 
media. 
The above supplementary tables are too large to include here, but are available 
in the supplementary data of, J.E. Griffin, J.D. Gawronski, M.A. DeJesus, T.R. 
Ioerger, B.J. Akerley, C.M. Sassetti Quantitiative high-resolution phenotypic 
profiling defines genes essential for Mycobacterium tuberculosis survival and 
cholesterol catabolism 
 
 
 
Supplementary Table 4.1 Carbon source-dependent metabolomic profiling.  
 
“Ratio Cholesterol/Glycerol” = relative abundance of metabolite in cholesterol / 
relative abundance of metabolite in glycerol 
 
“P-Value” = calculated using student t-test on quadruplicate samples 
 
  Ratio   
BIOCHEMICAL NAME Cholesterol /  Glycerol 
P-
VALUE 
5-methylthioadenosine (MTA) 2.19 0.0854 
phenylalanine 1.47 0.1810 
tryptophan 2.07 0.0226 
tyrosine 1.39 0.2113 
2-aminoadipate 5.54 0.0022 
alanine 2.02 0.0270 
asparagine 1.02 0.7070 
aspartate 1.16 0.7792 
beta-alanine 4.44 0.0098 
cadaverine 0.22 0.2884 
diaminopimelate 0.65 0.9722 
homoserine 1.35 0.2703 
lysine 3.39 0.0424 
%%.
N2-acetyllysine 0.09 0.1629 
N6-acetyllysine 1.43 0.1737 
N-6-trimethyllysine 1.82 0.0528 
O-acetylhomoserine 1.17 0.5363 
pipecolate 2.15 0.0230 
S-adenosylhomocysteine (SAH) 1.85 0.0432 
threonine 2.86 0.0218 
isoleucine 2.33 0.0376 
beta-hydroxyisovalerate 1.61 0.3293 
beta-methyllevulinate 1.65 0.2664 
leucine 2.15 0.0506 
methylsuccinate 16.28 < 0.001 
valine 1.86 0.0681 
2-aminobutyrate 1.33 0.2716 
2-pyrrolidinone 2.07 0.1016 
4-acetamidobutanoate 1.50 0.2523 
4-hydroxybutyrate (GHB) 2.33 0.0943 
arginine 1.42 0.3167 
citrulline 0.74 0.1119 
X - 11568 - retired for ergothioneine 1.57 0.1395 
gamma-aminobutyrate (GABA) 1.45 0.2528 
glutamate 1.53 0.2388 
glutamate, gamma-methyl ester 1.45 0.3784 
glutamine 1.83 0.1213 
histidine 2.90 0.0195 
N-acetylglutamate 1.45 0.2500 
N-acetylornithine 2.19 0.0079 
ornithine 1.81 0.2121 
proline 0.88 0.8975 
5-oxoproline 1.48 0.2714 
gamma-glutamyl-2-aminobutyrate 0.74 0.3052 
betaine 0.77 0.6220 
cysteine 1.22 0.5703 
glycine 0.95 0.7994 
serine 2.81 0.0259 
alanylalanine 1.62 0.0546 
gamma-glutamylalanine 1.52 0.0674 
gamma-glutamylglutamate 1.55 0.2489 
gamma-glutamylglutamine 1.25 0.1966 
gamma-glutamylisoleucine* 1.87 0.0899 
gamma-glutamylleucine 1.31 0.3244 
gamma-glutamylmethionine 1.21 0.3419 
%%%
X - 10821 - retired for gamma-
glutamylmethionine 1.41 0.2843 
gamma-glutamylphenylalanine 1.02 0.7569 
gamma-glutamylthreonine* 1.90 0.0205 
gamma-glutamyltyrosine 0.92 0.9901 
gamma-glutamylvaline 1.58 0.1143 
adenosine-5'-diphosphoglucose 3.45 0.0103 
3-phosphoglycerate 1.00   
dihydroxyacetone phosphate (DHAP) 1.30 0.3910 
2-isopropylmalate 1.57 0.3252 
fructose-6-phosphate 2.04 0.1247 
glucose 2.16 0.4840 
glucose 1-phosphate 2.15 0.4424 
glucose-6-phosphate (G6P) 3.17 0.0582 
glycerate 1.20 0.4595 
Isobar: fructose 1,6-diphosphate, glucose 
1,6-diphosphate 1.00   
pyruvate 1.97 0.1416 
inositol 1-phosphate (I1P) 0.63 0.4418 
myo-inositol 0.78 0.7872 
glycolate (hydroxyacetate) 1.43 0.1634 
Isobar: ribulose 5-phosphate, xylulose 5-
phosphate 1.10 0.8090 
ribose 5-phosphate 2.70 0.1055 
sedoheptulose-7-phosphate 2.50 0.1110 
fructose 1.69 0.2470 
GDP-mannose 1.27 0.6003 
malitol 2.63 0.0826 
maltose 2.82 0.0618 
maltotetraose 1.64 0.3749 
maltotriose 2.06 0.1699 
mannose 4.02 0.0494 
mannose-1-phosphate 5.34 0.0125 
mannose-6-phosphate 3.06 0.0507 
sorbitol 0.98 0.7253 
trehalose 1.58 0.1840 
trehalose 6-phosphate 5.17 0.0224 
X - 11011 - retired for 2-methylcitrate 22.81 < 0.001 
alpha-ketoglutarate 2.42 0.1283 
cis-aconitate 1.94 0.0690 
citrate 4.02 0.0054 
fumarate 2.95 0.0371 
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malate 5.49 0.0120 
succinate 4.67 0.0022 
succinyl CoA 1.91 0.1835 
1-octadecanol 0.63 0.7341 
arachidate (20:0) 0.70 0.3207 
caproate (6:0) 1.49 0.2339 
caprylate (8:0) 1.18 0.3959 
eicosenoate (20:1n9 or 11) 1.07 0.8025 
linoleamide (18:2n6) 0.28 0.0514 
linoleate (18:2n6) 1.17 0.8898 
margarate (17:0) 0.94 0.8777 
myristate (14:0) 1.08 0.5795 
n-Butyl Oleate 2.01 0.3080 
oleamide 0.11 < 0.001 
oleate (18:1n9) 1.97 0.3420 
palmitate (16:0) 0.94 0.8019 
pentadecanoate (15:0) 1.18 0.4794 
stearate (18:0) 0.79 0.3902 
X - 13183 - retired for stearamide 0.47 0.0196 
1-stearoylglycerol (1-monostearin) 1.04 0.9502 
glycerol 0.09 0.0378 
1-palmitoylglycerophosphoinositol* 0.91 0.7839 
glycerol 2-phosphate 0.22 0.0089 
glycerol 3-phosphate (G3P) 0.07 0.0013 
glycerophosphorylcholine (GPC) 1.00   
7-alpha-hydroxycholesterol 8.90 0.0060 
7-beta-hydroxycholesterol 4.41 0.0616 
cholesterol 1.58 0.3172 
2'-deoxyadenosine 1.39 0.2563 
adenine 4.29 0.0586 
adenosine 1.27 0.3263 
adenosine 3',5'-cyclic monophosphate 
(cAMP) 1.11 0.7701 
adenosine 3'-monophosphate (3'-AMP) 2.48 0.1328 
adenosine 5'-monophosphate (AMP) 1.73 0.0305 
guanosine 0.94 0.5504 
guanosine 5'- monophosphate (GMP) 1.80 0.1436 
inosine 0.72 0.8938 
thymidine 5'-monophosphate 3.38 0.0294 
acetyl CoA 1.73 0.2986 
pantothenate 5.00 0.0024 
adenosine 5'diphosphoribose 2.50 0.2568 
%%'
nicotinamide adenine dinucleotide (NAD+) 1.00 0.7441 
nicotinate 3.66 0.0264 
nicotinate ribonucleoside* 2.91 0.0338 
nicotinic acid mononucleotide (NaMN) 2.20 0.0011 
methylphosphate 0.43 0.7192 
phosphate 1.11 0.9654 
flavin adenine dinucleotide (FAD) 2.32 0.0944 
flavin mononucleotide (FMN) 1.81 0.1027 
alpha-tocopherol 1.00   
diisopropanolamine 1.73 0.2027 
triethyleneglycol 1.67 0.1006 
X - 07887- retired for p-toluic acid  1.84 0.3311 
X - 02973 2.62 0.0197 
X - 03094 0.48 0.1306 
X - 04033 1.66 0.1780 
X - 04044 1.58 0.1119 
X - 04768 1.59 0.3000 
X - 05407 1.48 0.3071 
X - 05437 0.39 0.0708 
X - 06346 1.32 0.6263 
X - 08754 2.58 0.0388 
X - 08889 1.50 0.3927 
X - 08988 2.65 0.2003 
X - 10889 2.44 0.4393 
X - 11251 1.93 0.3696 
X - 11297 0.97 0.8966 
X - 11391 1.74 0.3745 
X - 11394 1.70 0.4539 
X - 11395 1.82 0.4523 
X - 11404 1.46 0.5208 
X - 11406_200 2.25 0.0014 
X - 11453 1.84 0.4326 
X - 11455 1.43 0.6571 
X - 11456 1.97 0.1755 
X - 11457 1.92 0.4031 
X - 11461 2.04 0.3025 
X - 11509 0.74 0.3543 
X - 11533 1.04 0.5873 
X - 11550 1.03 0.7752 
X - 11687_200 2.29 0.0524 
X - 11730 1.21 0.8751 
X - 11795 1.89 0.0473 
%%(
X - 11809 0.90 0.9005 
X - 11840 1.38 0.5042 
X - 11875 0.95 0.5852 
X - 11910 1.18 0.5004 
X - 12051 0.81 0.3731 
X - 12660 1.17 0.6596 
X - 12776 0.98 0.8125 
X - 12805 1.68 0.2807 
X - 12889_201 1.92 0.0842 
X - 13005 1.26 0.4297 
X - 13093 0.26 0.2625 
X - 13149 0.67 0.2942 
X - 13168 0.89 0.6008 
X - 13548 1.73 0.4464 
X - 13549 2.15 0.3927 
X - 13645 2.82 0.1428 
X - 13672 1.16 0.6364 
X - 13737 0.57 0.2719 
X - 13828 0.94 0.6603 
X - 13872 1.08 0.6826 
X - 14318 0.53 0.1841 
X - 14359 1.19 0.9505 
X - 14568 2.06 0.0233 
X - 14575 1.38 0.8869 
X - 14588 1.52 0.3618 
X - 14955 4.40 0.0044 
X - 15138 0.92 0.6365 
X - 15177 1.39 0.3367 
X - 15261 1.58 0.0609 
X - 15279 2.53 0.0795 
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